{'patient_id': 0, 'age_at_diagnosis': 75.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 10, 'mutation_count': nan, 'nottingham_prognostic_index': 6.044, 'oncotree_code': 'IDC', 'overall_survival_months': 140.5, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2, 'age_at_diagnosis': 43.19, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 84.63333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5, 'age_at_diagnosis': 48.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 163.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6, 'age_at_diagnosis': 47.68, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 164.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 8, 'age_at_diagnosis': 76.97, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'MDLC', 'overall_survival_months': 41.36666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 10, 'age_at_diagnosis': 78.77, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.062, 'oncotree_code': 'IDC', 'overall_survival_months': 7.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 14, 'age_at_diagnosis': 56.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 164.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 22, 'age_at_diagnosis': 89.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.058, 'oncotree_code': 'MDLC', 'overall_survival_months': 99.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 28, 'age_at_diagnosis': 86.41, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'IDC', 'overall_survival_months': 36.56666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 35, 'age_at_diagnosis': 84.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.056, 'oncotree_code': 'ILC', 'overall_survival_months': 36.26666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 36, 'age_at_diagnosis': 85.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IDC', 'overall_survival_months': 132.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 39, 'age_at_diagnosis': 70.91, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.042, 'oncotree_code': 'IDC', 'overall_survival_months': 163.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 45, 'age_at_diagnosis': 45.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': nan, 'nottingham_prognostic_index': 5.038, 'oncotree_code': 'IDC', 'overall_survival_months': 164.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 46, 'age_at_diagnosis': 83.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 24, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.072, 'oncotree_code': 'IDC', 'overall_survival_months': 14.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 48, 'age_at_diagnosis': 51.46, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': nan, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 103.8333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 50, 'age_at_diagnosis': 44.64, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': nan, 'nottingham_prognostic_index': 4.066, 'oncotree_code': 'MDLC', 'overall_survival_months': 75.33333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 53, 'age_at_diagnosis': 70.02, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'IDC', 'overall_survival_months': 161.0666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 54, 'age_at_diagnosis': 66.91, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.072, 'oncotree_code': 'IDC', 'overall_survival_months': 160.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 56, 'age_at_diagnosis': 62.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.058, 'oncotree_code': 'MDLC', 'overall_survival_months': 62.86666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 60, 'age_at_diagnosis': 45.43, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 140.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 62, 'age_at_diagnosis': 52.14, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 153.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 64, 'age_at_diagnosis': 69.13, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 108.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 66, 'age_at_diagnosis': 61.49, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 157.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 68, 'age_at_diagnosis': 51.01, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 103.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 79, 'age_at_diagnosis': 50.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'IDC', 'overall_survival_months': 28.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 81, 'age_at_diagnosis': 49.61, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.048, 'oncotree_code': 'IDC', 'overall_survival_months': 69.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 83, 'age_at_diagnosis': 64.85, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'ILC', 'overall_survival_months': 86.06666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 93, 'age_at_diagnosis': 43.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.028, 'oncotree_code': 'MDLC', 'overall_survival_months': 153.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 95, 'age_at_diagnosis': 80.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.11, 'oncotree_code': 'IDC', 'overall_survival_months': 49.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 97, 'age_at_diagnosis': 78.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 98.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 100, 'age_at_diagnosis': 68.68, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.078, 'oncotree_code': 'IDC', 'overall_survival_months': 8.066666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 101, 'age_at_diagnosis': 46.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.068, 'oncotree_code': 'ILC', 'overall_survival_months': 148.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 102, 'age_at_diagnosis': 51.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 16, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'ILC', 'overall_survival_months': 140.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 106, 'age_at_diagnosis': 49.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.14, 'oncotree_code': 'IDC', 'overall_survival_months': 85.33333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 107, 'age_at_diagnosis': 65.59, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 158.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 108, 'age_at_diagnosis': 43.15, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 42.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 109, 'age_at_diagnosis': 82.53, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.09, 'oncotree_code': 'IDC', 'overall_survival_months': 112.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 111, 'age_at_diagnosis': 54.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.054, 'oncotree_code': 'IDC', 'overall_survival_months': 127.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 112, 'age_at_diagnosis': 83.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 14, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.3, 'oncotree_code': 'ILC', 'overall_survival_months': 39.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 113, 'age_at_diagnosis': 36.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': nan, 'nottingham_prognostic_index': 5.034, 'oncotree_code': 'IDC', 'overall_survival_months': 43.16666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 114, 'age_at_diagnosis': 48.59, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 13.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 115, 'age_at_diagnosis': 39.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 66.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 116, 'age_at_diagnosis': 42.55, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.12, 'oncotree_code': 'ILC', 'overall_survival_months': 122.2666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 117, 'age_at_diagnosis': 60.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'MDLC', 'overall_survival_months': 2.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 119, 'age_at_diagnosis': 82.73, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 95.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 120, 'age_at_diagnosis': 72.1, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'IDC', 'overall_survival_months': 29.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 121, 'age_at_diagnosis': 78.73, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 152.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 122, 'age_at_diagnosis': 58.95, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 138.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 123, 'age_at_diagnosis': 76.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 114.2333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 124, 'age_at_diagnosis': 43.46, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'MDLC', 'overall_survival_months': 118.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 125, 'age_at_diagnosis': 73.98, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.018, 'oncotree_code': 'MDLC', 'overall_survival_months': 1.266666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 126, 'age_at_diagnosis': 61.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.07, 'oncotree_code': 'IDC', 'overall_survival_months': 127.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 127, 'age_at_diagnosis': 52.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 132.0666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 128, 'age_at_diagnosis': 57.4, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'IDC', 'overall_survival_months': 137.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 129, 'age_at_diagnosis': 63.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': nan, 'nottingham_prognostic_index': 6.048, 'oncotree_code': 'IDC', 'overall_survival_months': 38.56666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 130, 'age_at_diagnosis': 56.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 2.034, 'oncotree_code': 'IDC', 'overall_survival_months': 153.5666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 131, 'age_at_diagnosis': 69.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.078, 'oncotree_code': 'IDC', 'overall_survival_months': 66.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 133, 'age_at_diagnosis': 58.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.16, 'oncotree_code': 'MDLC', 'overall_survival_months': 151.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 134, 'age_at_diagnosis': 73.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 12.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 135, 'age_at_diagnosis': 74.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': nan, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 116.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 136, 'age_at_diagnosis': 72.3, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'IDC', 'overall_survival_months': 88.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 138, 'age_at_diagnosis': 51.33, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 150.5666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 139, 'age_at_diagnosis': 47.62, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'ILC', 'overall_survival_months': 109.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 140, 'age_at_diagnosis': 74.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 147.9333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 142, 'age_at_diagnosis': 57.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'MDLC', 'overall_survival_months': 12.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 143, 'age_at_diagnosis': 85.39, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 54.33333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 144, 'age_at_diagnosis': 79.73, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.052, 'oncotree_code': 'IDC', 'overall_survival_months': 152.0666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 145, 'age_at_diagnosis': 62.4, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'ILC', 'overall_survival_months': 147.6666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 146, 'age_at_diagnosis': 81.0, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': nan, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 122.1666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 147, 'age_at_diagnosis': 79.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 9, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.076, 'oncotree_code': 'ILC', 'overall_survival_months': 51.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 148, 'age_at_diagnosis': 53.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.038, 'oncotree_code': 'IDC', 'overall_survival_months': 1.766666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 149, 'age_at_diagnosis': 77.13, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.078, 'oncotree_code': 'IDC', 'overall_survival_months': 51.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 150, 'age_at_diagnosis': 70.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 111.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 151, 'age_at_diagnosis': 67.7, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 49.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 152, 'age_at_diagnosis': 63.77, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.024, 'oncotree_code': 'IDC', 'overall_survival_months': 63.03333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 154, 'age_at_diagnosis': 62.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 114.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 155, 'age_at_diagnosis': 62.72, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.018, 'oncotree_code': 'IDC', 'overall_survival_months': 59.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 157, 'age_at_diagnosis': 71.5, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 114.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 162, 'age_at_diagnosis': 57.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'MDLC', 'overall_survival_months': 55.76666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 163, 'age_at_diagnosis': 84.73, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 14.0, 'nottingham_prognostic_index': 5.054, 'oncotree_code': 'IDC', 'overall_survival_months': 98.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 164, 'age_at_diagnosis': 37.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 10.83333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 165, 'age_at_diagnosis': 53.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 22, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.104, 'oncotree_code': 'IDC', 'overall_survival_months': 47.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 166, 'age_at_diagnosis': 44.98, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.048, 'oncotree_code': 'IDC', 'overall_survival_months': 104.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 167, 'age_at_diagnosis': 76.4, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.076, 'oncotree_code': 'IDC', 'overall_survival_months': 43.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 168, 'age_at_diagnosis': 60.26, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 122.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 170, 'age_at_diagnosis': 83.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'IDC', 'overall_survival_months': 93.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 171, 'age_at_diagnosis': 64.57, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'MDLC', 'overall_survival_months': 5.433333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 172, 'age_at_diagnosis': 48.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 138.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 173, 'age_at_diagnosis': 83.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.088, 'oncotree_code': 'IDC', 'overall_survival_months': 3.766666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 174, 'age_at_diagnosis': 59.18, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.048, 'oncotree_code': 'IDC', 'overall_survival_months': 78.76666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 175, 'age_at_diagnosis': 69.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 72.36666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 176, 'age_at_diagnosis': 38.78, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.072, 'oncotree_code': 'IDC', 'overall_survival_months': 113.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 177, 'age_at_diagnosis': 85.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.088, 'oncotree_code': 'MDLC', 'overall_survival_months': 45.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 178, 'age_at_diagnosis': 74.63, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 104.4666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 179, 'age_at_diagnosis': 56.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': nan, 'nottingham_prognostic_index': 6.068, 'oncotree_code': 'IDC', 'overall_survival_months': 17.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 180, 'age_at_diagnosis': 51.69, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 62.33333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 181, 'age_at_diagnosis': 68.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 85.96666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 184, 'age_at_diagnosis': 68.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IMMC', 'overall_survival_months': 109.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 188, 'age_at_diagnosis': 82.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.09, 'oncotree_code': 'ILC', 'overall_survival_months': 31.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 189, 'age_at_diagnosis': 57.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.096, 'oncotree_code': 'IDC', 'overall_survival_months': 9.066666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 191, 'age_at_diagnosis': 81.02, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 15.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 192, 'age_at_diagnosis': 62.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.026, 'oncotree_code': 'MDLC', 'overall_survival_months': 144.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 193, 'age_at_diagnosis': 51.54, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 7, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.038, 'oncotree_code': 'IDC', 'overall_survival_months': 19.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 194, 'age_at_diagnosis': 56.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'IDC', 'overall_survival_months': 91.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 195, 'age_at_diagnosis': 75.18, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 21, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.056, 'oncotree_code': 'IDC', 'overall_survival_months': 146.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 197, 'age_at_diagnosis': 50.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.048, 'oncotree_code': 'IDC', 'overall_survival_months': 70.73333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 198, 'age_at_diagnosis': 43.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.036, 'oncotree_code': 'IDC', 'overall_survival_months': 144.7666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 199, 'age_at_diagnosis': 57.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.038, 'oncotree_code': 'MDLC', 'overall_survival_months': 144.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 200, 'age_at_diagnosis': 69.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.076, 'oncotree_code': 'IDC', 'overall_survival_months': 130.8666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 201, 'age_at_diagnosis': 49.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 125.7, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 202, 'age_at_diagnosis': 46.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 128.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 203, 'age_at_diagnosis': 86.24, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 58.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 204, 'age_at_diagnosis': 79.38, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.02, 'oncotree_code': 'IDC', 'overall_survival_months': 24.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 205, 'age_at_diagnosis': 53.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'ILC', 'overall_survival_months': 144.4666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 206, 'age_at_diagnosis': 55.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 141.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 207, 'age_at_diagnosis': 48.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'MDLC', 'overall_survival_months': 173.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 209, 'age_at_diagnosis': 67.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.006, 'oncotree_code': 'IDC', 'overall_survival_months': 82.36666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 211, 'age_at_diagnosis': 42.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 13, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'IDC', 'overall_survival_months': 44.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 214, 'age_at_diagnosis': 41.41, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 146.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 215, 'age_at_diagnosis': 75.63, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'MDLC', 'overall_survival_months': 122.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 218, 'age_at_diagnosis': 43.39, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 131.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 220, 'age_at_diagnosis': 37.24, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 39.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 221, 'age_at_diagnosis': 77.72, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 7, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 20.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 222, 'age_at_diagnosis': 50.31, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'ILC', 'overall_survival_months': 212.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 223, 'age_at_diagnosis': 50.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 12, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 81.33333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 224, 'age_at_diagnosis': 44.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 176.7666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 225, 'age_at_diagnosis': 59.15, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.038, 'oncotree_code': 'IDC', 'overall_survival_months': 212.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 226, 'age_at_diagnosis': 58.21, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 57.63333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 227, 'age_at_diagnosis': 52.95, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.048, 'oncotree_code': 'IDC', 'overall_survival_months': 111.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 228, 'age_at_diagnosis': 63.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'ILC', 'overall_survival_months': 10.83333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 229, 'age_at_diagnosis': 45.5, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.038, 'oncotree_code': 'MDLC', 'overall_survival_months': 71.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 230, 'age_at_diagnosis': 41.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': nan, 'er_status': 'Negative', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 1.07, 'oncotree_code': 'IDC', 'overall_survival_months': 200.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 231, 'age_at_diagnosis': 71.57, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 1.06, 'oncotree_code': 'IMMC', 'overall_survival_months': 19.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 232, 'age_at_diagnosis': 44.73, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'IDC', 'overall_survival_months': 207.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 233, 'age_at_diagnosis': 77.77, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 72.43333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 234, 'age_at_diagnosis': 56.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'MDLC', 'overall_survival_months': 94.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 235, 'age_at_diagnosis': 52.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 142.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 236, 'age_at_diagnosis': 43.63, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 205.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 238, 'age_at_diagnosis': 52.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 193.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 239, 'age_at_diagnosis': 77.85, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.092, 'oncotree_code': 'MDLC', 'overall_survival_months': 85.56666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 241, 'age_at_diagnosis': 55.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.058, 'oncotree_code': 'IDC', 'overall_survival_months': 73.13333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 242, 'age_at_diagnosis': 51.25, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 199.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 243, 'age_at_diagnosis': 53.72, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 149.7666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 244, 'age_at_diagnosis': 67.83, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 2.022, 'oncotree_code': 'IDC', 'overall_survival_months': 149.7333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 245, 'age_at_diagnosis': 54.76, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 1.028, 'oncotree_code': 'ILC', 'overall_survival_months': 164.7, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 247, 'age_at_diagnosis': 66.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 185.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 248, 'age_at_diagnosis': 45.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 71.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 249, 'age_at_diagnosis': 53.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.022, 'oncotree_code': 'IDC', 'overall_survival_months': 188.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 253, 'age_at_diagnosis': 69.19, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 152.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 256, 'age_at_diagnosis': 53.1, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.034, 'oncotree_code': 'IDC', 'overall_survival_months': 200.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 257, 'age_at_diagnosis': 57.61, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 91.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 258, 'age_at_diagnosis': 62.7, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.022, 'oncotree_code': 'IDC', 'overall_survival_months': 86.13333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 259, 'age_at_diagnosis': 38.99, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 9, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.0, 'oncotree_code': 'IDC', 'overall_survival_months': 11.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 260, 'age_at_diagnosis': 78.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 1.024, 'oncotree_code': 'IDC', 'overall_survival_months': 169.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 261, 'age_at_diagnosis': 63.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'IDC', 'overall_survival_months': 90.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 262, 'age_at_diagnosis': 55.44, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'IDC', 'overall_survival_months': 182.2666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 263, 'age_at_diagnosis': 76.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 1.054, 'oncotree_code': 'MDLC', 'overall_survival_months': 176.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 264, 'age_at_diagnosis': 83.93, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.062, 'oncotree_code': 'IDC', 'overall_survival_months': 43.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 265, 'age_at_diagnosis': 46.44, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 189.1333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 266, 'age_at_diagnosis': 84.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 1.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 90.66666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 268, 'age_at_diagnosis': 66.54, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.038, 'oncotree_code': 'IDC', 'overall_survival_months': 28.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 269, 'age_at_diagnosis': 45.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'IDC', 'overall_survival_months': 22.23333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 270, 'age_at_diagnosis': 29.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'IDC', 'overall_survival_months': 337.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 272, 'age_at_diagnosis': 55.36, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.056, 'oncotree_code': 'IDC', 'overall_survival_months': 122.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 273, 'age_at_diagnosis': 68.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 186.5333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 275, 'age_at_diagnosis': 61.94, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 2.018, 'oncotree_code': 'IDC', 'overall_survival_months': 186.1, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 278, 'age_at_diagnosis': 34.3, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 3, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.106, 'oncotree_code': 'IDC', 'overall_survival_months': 5.833333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 279, 'age_at_diagnosis': 69.52, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 2.042, 'oncotree_code': 'ILC', 'overall_survival_months': 192.2666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 280, 'age_at_diagnosis': 47.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.042, 'oncotree_code': 'IDC', 'overall_survival_months': 172.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 282, 'age_at_diagnosis': 51.81, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.036, 'oncotree_code': 'MDLC', 'overall_survival_months': 194.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 284, 'age_at_diagnosis': 51.42, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Sarcoma', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': nan, 'er_status': 'Negative', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 1.0, 'oncotree_code': 'IDC', 'overall_survival_months': 0.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 285, 'age_at_diagnosis': 48.07, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 14, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 3.366666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 286, 'age_at_diagnosis': 62.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 192.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 287, 'age_at_diagnosis': 77.54, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.038, 'oncotree_code': 'IDC', 'overall_survival_months': 94.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 288, 'age_at_diagnosis': 55.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 25, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 63.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 289, 'age_at_diagnosis': 75.91, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 71.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 290, 'age_at_diagnosis': 49.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.05, 'oncotree_code': 'IDC', 'overall_survival_months': 199.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 291, 'age_at_diagnosis': 51.19, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'IDC', 'overall_survival_months': 39.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 292, 'age_at_diagnosis': 80.34, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.11, 'oncotree_code': 'IDC', 'overall_survival_months': 49.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 293, 'age_at_diagnosis': 51.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 2.026, 'oncotree_code': 'IDC', 'overall_survival_months': 64.36666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 294, 'age_at_diagnosis': 46.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'IDC', 'overall_survival_months': 72.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 295, 'age_at_diagnosis': 47.13, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.018, 'oncotree_code': 'IDC', 'overall_survival_months': 164.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 301, 'age_at_diagnosis': 82.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.046, 'oncotree_code': 'IDC', 'overall_survival_months': 122.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 302, 'age_at_diagnosis': 81.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.058, 'oncotree_code': 'ILC', 'overall_survival_months': 84.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 303, 'age_at_diagnosis': 47.71, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.022, 'oncotree_code': 'IDC', 'overall_survival_months': 60.13333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 304, 'age_at_diagnosis': 84.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.028, 'oncotree_code': 'IDC', 'overall_survival_months': 111.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 305, 'age_at_diagnosis': 60.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 63.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 306, 'age_at_diagnosis': 82.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 21.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 42.96666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 307, 'age_at_diagnosis': 41.63, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': nan, 'nottingham_prognostic_index': 6.02, 'oncotree_code': 'IDC', 'overall_survival_months': 177.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 308, 'age_at_diagnosis': 51.21, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.038, 'oncotree_code': 'BREAST', 'overall_survival_months': 183.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 309, 'age_at_diagnosis': 89.43, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.042, 'oncotree_code': 'IDC', 'overall_survival_months': 42.33333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 310, 'age_at_diagnosis': 67.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 185.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 311, 'age_at_diagnosis': 77.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.094, 'oncotree_code': 'IDC', 'overall_survival_months': 151.1666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 312, 'age_at_diagnosis': 70.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.066, 'oncotree_code': 'ILC', 'overall_survival_months': 169.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 313, 'age_at_diagnosis': 55.52, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.046, 'oncotree_code': 'IDC', 'overall_survival_months': 184.7666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 314, 'age_at_diagnosis': 73.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 4.433333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 315, 'age_at_diagnosis': 56.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 186.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 316, 'age_at_diagnosis': 50.82, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 182.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 317, 'age_at_diagnosis': 76.68, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.078, 'oncotree_code': 'IDC', 'overall_survival_months': 151.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 318, 'age_at_diagnosis': 58.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 1.036, 'oncotree_code': 'BREAST', 'overall_survival_months': 168.7, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 319, 'age_at_diagnosis': 92.14, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 10, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.064, 'oncotree_code': 'MDLC', 'overall_survival_months': 40.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 320, 'age_at_diagnosis': 50.98, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 2.034, 'oncotree_code': 'MDLC', 'overall_survival_months': 63.73333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 321, 'age_at_diagnosis': 46.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 174.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 322, 'age_at_diagnosis': 86.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 50.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 324, 'age_at_diagnosis': 47.64, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.064, 'oncotree_code': 'IDC', 'overall_survival_months': 144.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 325, 'age_at_diagnosis': 79.34, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.09, 'oncotree_code': 'IDC', 'overall_survival_months': 177.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 328, 'age_at_diagnosis': 69.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.068, 'oncotree_code': nan, 'overall_survival_months': 125.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 336, 'age_at_diagnosis': 74.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 170.6333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 339, 'age_at_diagnosis': 90.43, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.048, 'oncotree_code': 'IMMC', 'overall_survival_months': 26.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 340, 'age_at_diagnosis': 79.97, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'IDC', 'overall_survival_months': 164.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 341, 'age_at_diagnosis': 67.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 3, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': nan, 'overall_survival_months': 173.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 342, 'age_at_diagnosis': 54.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.058, 'oncotree_code': 'ILC', 'overall_survival_months': 125.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 343, 'age_at_diagnosis': 70.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 91.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 344, 'age_at_diagnosis': 59.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.058, 'oncotree_code': 'ILC', 'overall_survival_months': 152.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 345, 'age_at_diagnosis': 37.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'IDC', 'overall_survival_months': 72.66666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 346, 'age_at_diagnosis': 32.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.032, 'oncotree_code': 'IDC', 'overall_survival_months': 20.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 348, 'age_at_diagnosis': 81.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.044, 'oncotree_code': 'IDC', 'overall_survival_months': 122.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 349, 'age_at_diagnosis': 72.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 146.0333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 350, 'age_at_diagnosis': 49.05, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.16, 'oncotree_code': 'IDC', 'overall_survival_months': 46.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 352, 'age_at_diagnosis': 61.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 55.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 353, 'age_at_diagnosis': 86.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 41.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 354, 'age_at_diagnosis': 73.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.034, 'oncotree_code': 'IDC', 'overall_survival_months': 11.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 356, 'age_at_diagnosis': 58.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 213.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 358, 'age_at_diagnosis': 57.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 14.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'IDC', 'overall_survival_months': 32.86666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 359, 'age_at_diagnosis': 44.21, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IDC', 'overall_survival_months': 21.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 360, 'age_at_diagnosis': 83.58, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.1, 'oncotree_code': 'IDC', 'overall_survival_months': 132.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 361, 'age_at_diagnosis': 40.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 41, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.048, 'oncotree_code': 'IDC', 'overall_survival_months': 15.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 362, 'age_at_diagnosis': 52.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 47.03333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 363, 'age_at_diagnosis': 73.24, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 22.0, 'nottingham_prognostic_index': 5.134, 'oncotree_code': 'MDLC', 'overall_survival_months': 89.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 364, 'age_at_diagnosis': 48.67, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.1, 'oncotree_code': 'IDC', 'overall_survival_months': 176.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 365, 'age_at_diagnosis': 76.84, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IMMC', 'overall_survival_months': 87.23333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 366, 'age_at_diagnosis': 51.74, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'MDLC', 'overall_survival_months': 64.23333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 367, 'age_at_diagnosis': 70.98, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.018, 'oncotree_code': 'MDLC', 'overall_survival_months': 142.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 368, 'age_at_diagnosis': 74.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 10, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.062, 'oncotree_code': 'IDC', 'overall_survival_months': 61.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 369, 'age_at_diagnosis': 65.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 7, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.054, 'oncotree_code': 'ILC', 'overall_survival_months': 144.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 370, 'age_at_diagnosis': 64.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 16, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.094, 'oncotree_code': 'IDC', 'overall_survival_months': 93.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 371, 'age_at_diagnosis': 78.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.044, 'oncotree_code': 'IDC', 'overall_survival_months': 131.1333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 372, 'age_at_diagnosis': 39.86, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 62.76666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 373, 'age_at_diagnosis': 63.31, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.048, 'oncotree_code': 'IDC', 'overall_survival_months': 27.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 374, 'age_at_diagnosis': 34.68, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 15, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'IDC', 'overall_survival_months': 1.433333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 375, 'age_at_diagnosis': 72.69, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.046, 'oncotree_code': 'IDC', 'overall_survival_months': 143.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 377, 'age_at_diagnosis': 63.25, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 134.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 378, 'age_at_diagnosis': 57.15, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 13.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 97.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 379, 'age_at_diagnosis': 48.22, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.058, 'oncotree_code': 'IDC', 'overall_survival_months': 135.6666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 380, 'age_at_diagnosis': 83.9, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 69.33333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 381, 'age_at_diagnosis': 33.65, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 130.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 382, 'age_at_diagnosis': 59.05, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 136.4666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 383, 'age_at_diagnosis': 65.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.038, 'oncotree_code': 'IDC', 'overall_survival_months': 85.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 384, 'age_at_diagnosis': 74.58, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 13, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.086, 'oncotree_code': 'IDC', 'overall_survival_months': 61.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 385, 'age_at_diagnosis': 66.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 11, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.062, 'oncotree_code': 'IDC', 'overall_survival_months': 36.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 386, 'age_at_diagnosis': 66.83, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.03, 'oncotree_code': 'IDC', 'overall_survival_months': 138.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 388, 'age_at_diagnosis': 46.63, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 97.56666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 389, 'age_at_diagnosis': 46.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 19, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 96.96666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 391, 'age_at_diagnosis': 61.23, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 15, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 142.4666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 392, 'age_at_diagnosis': 56.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 38.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 393, 'age_at_diagnosis': 68.74, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 16, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.106, 'oncotree_code': 'IDC', 'overall_survival_months': 20.83333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 394, 'age_at_diagnosis': 56.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 64.23333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 395, 'age_at_diagnosis': 80.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 11.0, 'nottingham_prognostic_index': 5.1, 'oncotree_code': 'IDC', 'overall_survival_months': 29.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 396, 'age_at_diagnosis': 56.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 60.66666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 397, 'age_at_diagnosis': 58.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.022, 'oncotree_code': 'IDC', 'overall_survival_months': 57.23333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 398, 'age_at_diagnosis': 56.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 19, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.084, 'oncotree_code': 'IDC', 'overall_survival_months': 43.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 399, 'age_at_diagnosis': 68.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 11, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.09, 'oncotree_code': 'IDC', 'overall_survival_months': 137.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 400, 'age_at_diagnosis': 55.28, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 22.46666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 401, 'age_at_diagnosis': 48.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 26.26666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 402, 'age_at_diagnosis': 73.06, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 2.022, 'oncotree_code': 'IDC', 'overall_survival_months': 99.73333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 404, 'age_at_diagnosis': 60.71, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 63.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 406, 'age_at_diagnosis': 69.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 17, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.36, 'oncotree_code': 'IDC', 'overall_survival_months': 96.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 410, 'age_at_diagnosis': 57.41, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'ILC', 'overall_survival_months': 63.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 411, 'age_at_diagnosis': 54.6, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'MDLC', 'overall_survival_months': 139.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 412, 'age_at_diagnosis': 54.06, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.038, 'oncotree_code': 'IDC', 'overall_survival_months': 136.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 413, 'age_at_diagnosis': 56.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.094, 'oncotree_code': 'IDC', 'overall_survival_months': 140.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 414, 'age_at_diagnosis': 72.16, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 76.63333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 417, 'age_at_diagnosis': 54.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 6.266666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 418, 'age_at_diagnosis': 58.72, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.062, 'oncotree_code': 'IDC', 'overall_survival_months': 102.0666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 419, 'age_at_diagnosis': 77.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 104.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 420, 'age_at_diagnosis': 34.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 76.73333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 421, 'age_at_diagnosis': 73.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.048, 'oncotree_code': 'IDC', 'overall_survival_months': 93.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 422, 'age_at_diagnosis': 66.72, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'IDC', 'overall_survival_months': 33.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 424, 'age_at_diagnosis': 44.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 22, 'mutation_count': nan, 'nottingham_prognostic_index': 6.12, 'oncotree_code': 'IDC', 'overall_survival_months': 9.833333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 425, 'age_at_diagnosis': 83.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 24.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 426, 'age_at_diagnosis': 50.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.084, 'oncotree_code': 'IDC', 'overall_survival_months': 131.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 427, 'age_at_diagnosis': 81.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 15, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'ILC', 'overall_survival_months': 116.1, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 428, 'age_at_diagnosis': 85.21, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 55.93333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 429, 'age_at_diagnosis': 78.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'ILC', 'overall_survival_months': 74.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 431, 'age_at_diagnosis': 63.61, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.114, 'oncotree_code': 'ILC', 'overall_survival_months': 85.13333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 434, 'age_at_diagnosis': 69.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 45.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 436, 'age_at_diagnosis': 88.29, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 75.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 437, 'age_at_diagnosis': 82.17, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 90.56666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 438, 'age_at_diagnosis': 57.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 135.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 439, 'age_at_diagnosis': 50.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IMMC', 'overall_survival_months': 112.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 440, 'age_at_diagnosis': 56.73, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'IDC', 'overall_survival_months': 100.8333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 442, 'age_at_diagnosis': 71.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 103.4666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 443, 'age_at_diagnosis': 61.67, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'IDC', 'overall_survival_months': 45.03333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 444, 'age_at_diagnosis': 49.87, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 18, 'mutation_count': nan, 'nottingham_prognostic_index': 5.066, 'oncotree_code': 'ILC', 'overall_survival_months': 55.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 445, 'age_at_diagnosis': 40.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 132.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 446, 'age_at_diagnosis': 56.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.048, 'oncotree_code': 'IDC', 'overall_survival_months': 72.26666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 449, 'age_at_diagnosis': 54.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.07, 'oncotree_code': 'IDC', 'overall_survival_months': 112.5666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 451, 'age_at_diagnosis': 63.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.032, 'oncotree_code': 'IDC', 'overall_survival_months': 50.06666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 452, 'age_at_diagnosis': 54.43, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 62.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 453, 'age_at_diagnosis': 61.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.2, 'oncotree_code': 'IDC', 'overall_survival_months': 43.13333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 454, 'age_at_diagnosis': 90.02, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IMMC', 'overall_survival_months': 46.83333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 455, 'age_at_diagnosis': 56.84, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 99.33333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 458, 'age_at_diagnosis': 49.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 134.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 459, 'age_at_diagnosis': 85.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.068, 'oncotree_code': 'IDC', 'overall_survival_months': 35.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 460, 'age_at_diagnosis': 81.44, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'ILC', 'overall_survival_months': 114.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 462, 'age_at_diagnosis': 60.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 132.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 463, 'age_at_diagnosis': 60.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.042, 'oncotree_code': 'IDC', 'overall_survival_months': 120.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 464, 'age_at_diagnosis': 58.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 17, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.026, 'oncotree_code': 'IDC', 'overall_survival_months': 39.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 465, 'age_at_diagnosis': 87.18, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'IDC', 'overall_survival_months': 28.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 466, 'age_at_diagnosis': 33.97, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.14, 'oncotree_code': 'IDC', 'overall_survival_months': 43.86666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 467, 'age_at_diagnosis': 58.35, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 105.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 468, 'age_at_diagnosis': 60.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.052, 'oncotree_code': 'IDC', 'overall_survival_months': 129.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 469, 'age_at_diagnosis': 67.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.078, 'oncotree_code': 'IDC', 'overall_survival_months': 131.2666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 470, 'age_at_diagnosis': 61.78, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'ILC', 'overall_survival_months': 88.23333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 471, 'age_at_diagnosis': 76.49, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IMMC', 'overall_survival_months': 107.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 472, 'age_at_diagnosis': 59.34, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 1.022, 'oncotree_code': 'ILC', 'overall_survival_months': 27.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 474, 'age_at_diagnosis': 54.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.16, 'oncotree_code': 'IDC', 'overall_survival_months': 111.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 475, 'age_at_diagnosis': 54.15, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 130.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 476, 'age_at_diagnosis': 54.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 130.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 478, 'age_at_diagnosis': 74.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 132.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 479, 'age_at_diagnosis': 33.83, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 132.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 480, 'age_at_diagnosis': 51.86, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 94.56666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 481, 'age_at_diagnosis': 54.22, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.038, 'oncotree_code': 'IDC', 'overall_survival_months': 36.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 482, 'age_at_diagnosis': 39.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'IDC', 'overall_survival_months': 24.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 483, 'age_at_diagnosis': 49.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'IDC', 'overall_survival_months': 74.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 484, 'age_at_diagnosis': 38.72, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 82.63333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 485, 'age_at_diagnosis': 60.78, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'MDLC', 'overall_survival_months': 36.76666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 486, 'age_at_diagnosis': 57.57, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.064, 'oncotree_code': 'IDC', 'overall_survival_months': 89.96666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 487, 'age_at_diagnosis': 57.36, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 86.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 488, 'age_at_diagnosis': 50.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 2.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 112.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 489, 'age_at_diagnosis': 41.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 90.56666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 490, 'age_at_diagnosis': 81.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 10, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 101.9666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 491, 'age_at_diagnosis': 43.4, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'ILC', 'overall_survival_months': 125.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 492, 'age_at_diagnosis': 85.21, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'MDLC', 'overall_survival_months': 81.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 494, 'age_at_diagnosis': 77.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 21, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'IDC', 'overall_survival_months': 36.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 495, 'age_at_diagnosis': 63.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.038, 'oncotree_code': 'IDC', 'overall_survival_months': 71.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 496, 'age_at_diagnosis': 60.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'IDC', 'overall_survival_months': 130.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 497, 'age_at_diagnosis': 57.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.058, 'oncotree_code': 'IDC', 'overall_survival_months': 73.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 500, 'age_at_diagnosis': 36.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 67.46666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 501, 'age_at_diagnosis': 48.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 71.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 502, 'age_at_diagnosis': 56.41, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': nan, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'IDC', 'overall_survival_months': 82.1, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 503, 'age_at_diagnosis': 60.77, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'IDC', 'overall_survival_months': 101.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 504, 'age_at_diagnosis': 68.16, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 130.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 505, 'age_at_diagnosis': 56.38, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 60.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 506, 'age_at_diagnosis': 60.74, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'IDC', 'overall_survival_months': 45.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 507, 'age_at_diagnosis': 58.71, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 23.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 508, 'age_at_diagnosis': 42.68, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.022, 'oncotree_code': 'IDC', 'overall_survival_months': 114.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 509, 'age_at_diagnosis': 41.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.022, 'oncotree_code': 'IDC', 'overall_survival_months': 115.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 510, 'age_at_diagnosis': 71.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': nan, 'nottingham_prognostic_index': 5.12, 'oncotree_code': 'IDC', 'overall_survival_months': 128.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 511, 'age_at_diagnosis': 59.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.062, 'oncotree_code': 'IDC', 'overall_survival_months': 61.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 512, 'age_at_diagnosis': 56.74, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.048, 'oncotree_code': 'IDC', 'overall_survival_months': 121.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 513, 'age_at_diagnosis': 73.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.064, 'oncotree_code': 'IDC', 'overall_survival_months': 117.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 514, 'age_at_diagnosis': 42.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': nan, 'overall_survival_months': 13.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 516, 'age_at_diagnosis': 62.81, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 114.4666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 517, 'age_at_diagnosis': 47.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 61.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 519, 'age_at_diagnosis': 61.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 23, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.13, 'oncotree_code': 'IDC', 'overall_survival_months': 110.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 521, 'age_at_diagnosis': 52.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'ILC', 'overall_survival_months': 212.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 522, 'age_at_diagnosis': 54.08, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.0, 'oncotree_code': nan, 'overall_survival_months': 2.5, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 524, 'age_at_diagnosis': 40.65, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 80.83333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 525, 'age_at_diagnosis': 48.47, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 65.86666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 526, 'age_at_diagnosis': 72.18, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 139.6333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 527, 'age_at_diagnosis': 73.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.038, 'oncotree_code': 'IDC', 'overall_survival_months': 109.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 528, 'age_at_diagnosis': 53.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'IDC', 'overall_survival_months': 193.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 529, 'age_at_diagnosis': 67.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 48.53333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 531, 'age_at_diagnosis': 60.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 163.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 532, 'age_at_diagnosis': 59.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 143.1333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 534, 'age_at_diagnosis': 51.56, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 12.0, 'nottingham_prognostic_index': 5.034, 'oncotree_code': 'IDC', 'overall_survival_months': 124.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 535, 'age_at_diagnosis': 46.66, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 199.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 536, 'age_at_diagnosis': 67.88, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 147.3666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 537, 'age_at_diagnosis': 59.8, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'IDC', 'overall_survival_months': 113.5666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 538, 'age_at_diagnosis': 61.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 26, 'mutation_count': nan, 'nottingham_prognostic_index': 6.074, 'oncotree_code': 'IDC', 'overall_survival_months': 24.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 540, 'age_at_diagnosis': 66.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 2.024, 'oncotree_code': 'MDLC', 'overall_survival_months': 194.5333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 541, 'age_at_diagnosis': 38.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.038, 'oncotree_code': 'IDC', 'overall_survival_months': 174.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 542, 'age_at_diagnosis': 39.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.046, 'oncotree_code': 'IDC', 'overall_survival_months': 48.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 544, 'age_at_diagnosis': 74.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.104, 'oncotree_code': 'IDC', 'overall_survival_months': 79.33333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 545, 'age_at_diagnosis': 83.92, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.052, 'oncotree_code': 'IDC', 'overall_survival_months': 41.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 550, 'age_at_diagnosis': 60.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 132.3333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 551, 'age_at_diagnosis': 76.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.064, 'oncotree_code': 'IDC', 'overall_survival_months': 51.96666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 552, 'age_at_diagnosis': 61.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.058, 'oncotree_code': 'IDC', 'overall_survival_months': 68.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 553, 'age_at_diagnosis': 86.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 14, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 85.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 554, 'age_at_diagnosis': 82.35, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 2.032, 'oncotree_code': 'IDC', 'overall_survival_months': 111.1666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 558, 'age_at_diagnosis': 69.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'IDC', 'overall_survival_months': 97.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 559, 'age_at_diagnosis': 47.71, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 161.7666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 568, 'age_at_diagnosis': 61.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 181.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 569, 'age_at_diagnosis': 74.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 14, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.046, 'oncotree_code': 'IDC', 'overall_survival_months': 59.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 570, 'age_at_diagnosis': 68.99, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 272.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 571, 'age_at_diagnosis': 61.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 149.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 573, 'age_at_diagnosis': 76.22, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.13, 'oncotree_code': 'IDC', 'overall_survival_months': 163.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 574, 'age_at_diagnosis': 71.21, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'IDC', 'overall_survival_months': 119.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 575, 'age_at_diagnosis': 48.1, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.11, 'oncotree_code': 'IDC', 'overall_survival_months': 128.5666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 576, 'age_at_diagnosis': 68.47, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.042, 'oncotree_code': 'IDC', 'overall_survival_months': 31.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 577, 'age_at_diagnosis': 51.42, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'IMMC', 'overall_survival_months': 65.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 578, 'age_at_diagnosis': 59.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.084, 'oncotree_code': 'ILC', 'overall_survival_months': 110.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 579, 'age_at_diagnosis': 70.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.058, 'oncotree_code': 'IDC', 'overall_survival_months': 92.76666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 580, 'age_at_diagnosis': 33.8, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 79.36666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 581, 'age_at_diagnosis': 96.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 14, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.052, 'oncotree_code': 'IDC', 'overall_survival_months': 7.866666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 582, 'age_at_diagnosis': 84.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'ILC', 'overall_survival_months': 15.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 583, 'age_at_diagnosis': 75.67, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'MDLC', 'overall_survival_months': 62.63333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 584, 'age_at_diagnosis': 41.31, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 118.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 585, 'age_at_diagnosis': 76.72, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 115.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 586, 'age_at_diagnosis': 77.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.13, 'oncotree_code': 'ILC', 'overall_survival_months': 77.23333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 587, 'age_at_diagnosis': 50.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.048, 'oncotree_code': 'MDLC', 'overall_survival_months': 91.26666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 588, 'age_at_diagnosis': 76.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IDC', 'overall_survival_months': 119.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 589, 'age_at_diagnosis': 59.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 25, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'MDLC', 'overall_survival_months': 125.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 590, 'age_at_diagnosis': 60.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 15, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'IDC', 'overall_survival_months': 72.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 591, 'age_at_diagnosis': 84.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 119.4666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 593, 'age_at_diagnosis': 62.34, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 13, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.18, 'oncotree_code': 'ILC', 'overall_survival_months': 34.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 594, 'age_at_diagnosis': 77.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.09, 'oncotree_code': 'IDC', 'overall_survival_months': 44.23333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 596, 'age_at_diagnosis': 77.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'MDLC', 'overall_survival_months': 107.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 597, 'age_at_diagnosis': 64.55, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 113.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 598, 'age_at_diagnosis': 77.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 9, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.048, 'oncotree_code': 'IDC', 'overall_survival_months': 89.36666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 599, 'age_at_diagnosis': 46.85, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.048, 'oncotree_code': 'IDC', 'overall_survival_months': 123.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 600, 'age_at_diagnosis': 70.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 9, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.054, 'oncotree_code': 'MDLC', 'overall_survival_months': 111.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 601, 'age_at_diagnosis': 32.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'IDC', 'overall_survival_months': 29.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 603, 'age_at_diagnosis': 79.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 121.9666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 605, 'age_at_diagnosis': 58.08, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'ILC', 'overall_survival_months': 114.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 606, 'age_at_diagnosis': 83.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'MDLC', 'overall_survival_months': 27.46666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 607, 'age_at_diagnosis': 53.1, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 87.83333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 608, 'age_at_diagnosis': 76.81, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 10.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'IDC', 'overall_survival_months': 63.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 609, 'age_at_diagnosis': 51.15, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'IDC', 'overall_survival_months': 98.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 610, 'age_at_diagnosis': 71.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': nan, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 76.7, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 611, 'age_at_diagnosis': 75.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.048, 'oncotree_code': 'IDC', 'overall_survival_months': 104.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 613, 'age_at_diagnosis': 60.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.12, 'oncotree_code': 'BREAST', 'overall_survival_months': 48.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 614, 'age_at_diagnosis': 48.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.038, 'oncotree_code': 'IDC', 'overall_survival_months': 119.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 615, 'age_at_diagnosis': 38.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 3, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.006, 'oncotree_code': 'IDC', 'overall_survival_months': 34.76666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 616, 'age_at_diagnosis': 75.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.076, 'oncotree_code': 'IDC', 'overall_survival_months': 29.03333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 617, 'age_at_diagnosis': 72.14, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 2.08, 'oncotree_code': 'IMMC', 'overall_survival_months': 92.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 618, 'age_at_diagnosis': 63.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 101.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 619, 'age_at_diagnosis': 38.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 94.23333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 620, 'age_at_diagnosis': 62.97, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': nan, 'nottingham_prognostic_index': 5.028, 'oncotree_code': 'BREAST', 'overall_survival_months': 112.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 621, 'age_at_diagnosis': 70.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'ILC', 'overall_survival_months': 33.56666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 623, 'age_at_diagnosis': 66.52, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 111.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 624, 'age_at_diagnosis': 64.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 64.03333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 626, 'age_at_diagnosis': 61.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 35.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 627, 'age_at_diagnosis': 54.1, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 0.766666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 628, 'age_at_diagnosis': 63.98, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'IDC', 'overall_survival_months': 105.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 630, 'age_at_diagnosis': 38.35, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 86.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 631, 'age_at_diagnosis': 84.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 47.43333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 632, 'age_at_diagnosis': 51.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 56.5, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 634, 'age_at_diagnosis': 55.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 4.01, 'oncotree_code': 'ILC', 'overall_survival_months': 17.76666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 636, 'age_at_diagnosis': 26.36, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.024, 'oncotree_code': 'IDC', 'overall_survival_months': 32.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 637, 'age_at_diagnosis': 75.71, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.062, 'oncotree_code': 'IDC', 'overall_survival_months': 80.66666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 638, 'age_at_diagnosis': 66.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.064, 'oncotree_code': 'MDLC', 'overall_survival_months': 103.7666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 639, 'age_at_diagnosis': 50.39, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 75.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 640, 'age_at_diagnosis': 66.09, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'IDC', 'overall_survival_months': 61.33333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 641, 'age_at_diagnosis': 56.34, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': nan, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'IDC', 'overall_survival_months': 102.5666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 642, 'age_at_diagnosis': 79.12, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 84.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 643, 'age_at_diagnosis': 73.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 12, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.12, 'oncotree_code': 'IDC', 'overall_survival_months': 19.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 644, 'age_at_diagnosis': 71.06, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 93.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 646, 'age_at_diagnosis': 67.06, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.066, 'oncotree_code': 'MDLC', 'overall_survival_months': 15.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 649, 'age_at_diagnosis': 60.62, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.016, 'oncotree_code': 'IDC', 'overall_survival_months': 61.43333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 650, 'age_at_diagnosis': 79.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 25.53333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 652, 'age_at_diagnosis': 85.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'IDC', 'overall_survival_months': 96.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 653, 'age_at_diagnosis': 69.95, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 22.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'ILC', 'overall_survival_months': 24.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 654, 'age_at_diagnosis': 82.5, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.048, 'oncotree_code': 'IDC', 'overall_survival_months': 69.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 655, 'age_at_diagnosis': 69.73, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 1.12, 'oncotree_code': 'BREAST', 'overall_survival_months': 111.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 656, 'age_at_diagnosis': 35.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.2, 'oncotree_code': 'IDC', 'overall_survival_months': 19.03333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 657, 'age_at_diagnosis': 58.65, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.2, 'oncotree_code': 'ILC', 'overall_survival_months': 30.43333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 658, 'age_at_diagnosis': 60.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 97.26666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 659, 'age_at_diagnosis': 82.87, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.09, 'oncotree_code': 'BREAST', 'overall_survival_months': 23.33333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 660, 'age_at_diagnosis': 52.43, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 22, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.32, 'oncotree_code': 'IDC', 'overall_survival_months': 18.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 661, 'age_at_diagnosis': 78.78, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 3.016, 'oncotree_code': 'IDC', 'overall_survival_months': 20.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 662, 'age_at_diagnosis': 50.94, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'IDC', 'overall_survival_months': 69.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 663, 'age_at_diagnosis': 57.76, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 55.36666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 664, 'age_at_diagnosis': 78.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 10, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.168, 'oncotree_code': 'IDC', 'overall_survival_months': 11.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 666, 'age_at_diagnosis': 61.31, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 9, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'IDC', 'overall_survival_months': 24.33333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 869, 'age_at_diagnosis': 58.83, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.058, 'oncotree_code': 'IDC', 'overall_survival_months': 112.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 872, 'age_at_diagnosis': 82.34, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'IDC', 'overall_survival_months': 152.0666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 874, 'age_at_diagnosis': 59.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.078, 'oncotree_code': 'IDC', 'overall_survival_months': 16.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 877, 'age_at_diagnosis': 79.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 14.43333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 880, 'age_at_diagnosis': 73.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 2.06, 'oncotree_code': 'IDC', 'overall_survival_months': 1.233333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 882, 'age_at_diagnosis': 73.39, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.094, 'oncotree_code': 'IDC', 'overall_survival_months': 42.36666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 884, 'age_at_diagnosis': 56.47, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 15, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.046, 'oncotree_code': 'IDC', 'overall_survival_months': 93.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 891, 'age_at_diagnosis': 83.68, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.074, 'oncotree_code': 'IDC', 'overall_survival_months': 149.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 893, 'age_at_diagnosis': 57.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': nan, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 175.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 895, 'age_at_diagnosis': 79.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.038, 'oncotree_code': 'IDC', 'overall_survival_months': 43.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 897, 'age_at_diagnosis': 41.32, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 1, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 28.0, 'nottingham_prognostic_index': 4.092, 'oncotree_code': 'IDC', 'overall_survival_months': 30.96666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 899, 'age_at_diagnosis': 50.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 175.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 901, 'age_at_diagnosis': 68.19, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.066, 'oncotree_code': 'IDC', 'overall_survival_months': 136.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 904, 'age_at_diagnosis': 83.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 1, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 144.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 906, 'age_at_diagnosis': 70.6, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 1, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'MDLC', 'overall_survival_months': 63.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2513, 'age_at_diagnosis': 57.96, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 59.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2517, 'age_at_diagnosis': 60.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 268.4333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2536, 'age_at_diagnosis': 54.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 47.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2556, 'age_at_diagnosis': 62.59, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'ILC', 'overall_survival_months': 220.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2564, 'age_at_diagnosis': 52.98, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 2.02, 'oncotree_code': 'IDC', 'overall_survival_months': 285.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2610, 'age_at_diagnosis': 58.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 280.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2613, 'age_at_diagnosis': 59.63, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 163.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2614, 'age_at_diagnosis': 43.72, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 10, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 64.93333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2616, 'age_at_diagnosis': 65.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'MDLC', 'overall_survival_months': 219.1666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2617, 'age_at_diagnosis': 63.3, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 89.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2618, 'age_at_diagnosis': 66.22, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 89.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2624, 'age_at_diagnosis': 53.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'IDC', 'overall_survival_months': 128.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2626, 'age_at_diagnosis': 62.54, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 193.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2629, 'age_at_diagnosis': 61.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 279.1, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2632, 'age_at_diagnosis': 36.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 19.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2634, 'age_at_diagnosis': 70.69, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 274.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2642, 'age_at_diagnosis': 30.67, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 45.16666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2643, 'age_at_diagnosis': 34.2, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': nan, 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.006, 'oncotree_code': 'IDC', 'overall_survival_months': 52.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2645, 'age_at_diagnosis': 69.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.054, 'oncotree_code': 'IDC', 'overall_survival_months': 44.76666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2669, 'age_at_diagnosis': 62.56, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.048, 'oncotree_code': 'IDC', 'overall_survival_months': 73.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2686, 'age_at_diagnosis': 68.76, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.034, 'oncotree_code': 'IDC', 'overall_survival_months': 177.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2705, 'age_at_diagnosis': 61.78, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 163.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2708, 'age_at_diagnosis': 66.36, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 133.2333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2711, 'age_at_diagnosis': 48.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 201.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2712, 'age_at_diagnosis': 54.59, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.022, 'oncotree_code': 'MDLC', 'overall_survival_months': 234.4333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2718, 'age_at_diagnosis': 47.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 278.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2721, 'age_at_diagnosis': 44.82, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.018, 'oncotree_code': 'IDC', 'overall_survival_months': 251.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2724, 'age_at_diagnosis': 60.59, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.016, 'oncotree_code': 'IDC', 'overall_survival_months': 108.0666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2725, 'age_at_diagnosis': 44.88, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 236.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2728, 'age_at_diagnosis': 28.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 11, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'IDC', 'overall_survival_months': 51.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2730, 'age_at_diagnosis': 61.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 10.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 133.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2735, 'age_at_diagnosis': 49.94, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.024, 'oncotree_code': 'IDC', 'overall_survival_months': 274.5, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2742, 'age_at_diagnosis': 48.25, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 24.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2744, 'age_at_diagnosis': 45.57, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'ILC', 'overall_survival_months': 275.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2745, 'age_at_diagnosis': 46.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 168.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2747, 'age_at_diagnosis': 68.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.038, 'oncotree_code': 'IDC', 'overall_survival_months': 234.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2749, 'age_at_diagnosis': 60.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.026, 'oncotree_code': 'IDC', 'overall_survival_months': 97.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2750, 'age_at_diagnosis': 47.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 145.4333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2752, 'age_at_diagnosis': 51.36, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.07, 'oncotree_code': 'MDLC', 'overall_survival_months': 81.93333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2753, 'age_at_diagnosis': 30.95, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.074, 'oncotree_code': 'IDC', 'overall_survival_months': 274.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2754, 'age_at_diagnosis': 66.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.07, 'oncotree_code': 'ILC', 'overall_survival_months': 203.5333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2758, 'age_at_diagnosis': 38.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.09, 'oncotree_code': 'IDC', 'overall_survival_months': 35.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2760, 'age_at_diagnosis': 63.1, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 118.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2763, 'age_at_diagnosis': 70.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'IMMC', 'overall_survival_months': 275.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2764, 'age_at_diagnosis': 57.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 270.1333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2765, 'age_at_diagnosis': 65.79, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 227.8666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2767, 'age_at_diagnosis': 53.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'IDC', 'overall_survival_months': 271.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2769, 'age_at_diagnosis': 59.9, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'ILC', 'overall_survival_months': 160.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2770, 'age_at_diagnosis': 60.32, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 10.0, 'nottingham_prognostic_index': 5.09, 'oncotree_code': 'ILC', 'overall_survival_months': 274.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2771, 'age_at_diagnosis': 56.79, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 44.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2772, 'age_at_diagnosis': 54.4, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'MDLC', 'overall_survival_months': 150.7333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2774, 'age_at_diagnosis': 66.06, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 131.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2778, 'age_at_diagnosis': 62.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'NC', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 181.2333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2779, 'age_at_diagnosis': 36.8, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 275.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2781, 'age_at_diagnosis': 64.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 40.43333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2786, 'age_at_diagnosis': 62.36, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 68.26666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2790, 'age_at_diagnosis': 47.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 116.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2791, 'age_at_diagnosis': 40.79, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 271.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2792, 'age_at_diagnosis': 50.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 110.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2793, 'age_at_diagnosis': 67.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 267.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2795, 'age_at_diagnosis': 42.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 272.1, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2796, 'age_at_diagnosis': 57.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 87.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2797, 'age_at_diagnosis': 50.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 252.9666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2801, 'age_at_diagnosis': 70.35, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 271.2666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2803, 'age_at_diagnosis': 63.01, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 85.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2814, 'age_at_diagnosis': 65.25, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'IDC', 'overall_survival_months': 231.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2815, 'age_at_diagnosis': 64.25, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.044, 'oncotree_code': 'MDLC', 'overall_survival_months': 257.5666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2819, 'age_at_diagnosis': 61.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.038, 'oncotree_code': 'MDLC', 'overall_survival_months': 270.5666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2820, 'age_at_diagnosis': 40.06, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 254.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2821, 'age_at_diagnosis': 57.39, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Metaplastic Breast Cancer', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Metaplastic', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 1.032, 'oncotree_code': 'MBC', 'overall_survival_months': 136.0666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2823, 'age_at_diagnosis': 35.97, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.022, 'oncotree_code': 'MDLC', 'overall_survival_months': 269.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2827, 'age_at_diagnosis': 36.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.022, 'oncotree_code': 'IDC', 'overall_survival_months': 235.6666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2833, 'age_at_diagnosis': 42.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.046, 'oncotree_code': 'IDC', 'overall_survival_months': 259.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2834, 'age_at_diagnosis': 56.85, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.018, 'oncotree_code': 'IDC', 'overall_survival_months': 153.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2835, 'age_at_diagnosis': 59.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 55.03333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2838, 'age_at_diagnosis': 67.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 3.054, 'oncotree_code': 'IDC', 'overall_survival_months': 270.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2840, 'age_at_diagnosis': 60.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'ILC', 'overall_survival_months': 269.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2842, 'age_at_diagnosis': 58.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 11.0, 'nottingham_prognostic_index': 5.054, 'oncotree_code': 'IDC', 'overall_survival_months': 19.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2843, 'age_at_diagnosis': 61.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'IDC', 'overall_survival_months': 231.5333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2844, 'age_at_diagnosis': 60.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.038, 'oncotree_code': 'IDC', 'overall_survival_months': 146.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2845, 'age_at_diagnosis': 55.8, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'ILC', 'overall_survival_months': 264.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2846, 'age_at_diagnosis': 58.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.01, 'oncotree_code': 'IDC', 'overall_survival_months': 149.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2847, 'age_at_diagnosis': 65.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 18, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 39.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2848, 'age_at_diagnosis': 60.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 227.7333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2849, 'age_at_diagnosis': 60.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'IDC', 'overall_survival_months': 43.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2850, 'age_at_diagnosis': 31.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 11, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.062, 'oncotree_code': 'IDC', 'overall_survival_months': 9.433333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2851, 'age_at_diagnosis': 58.69, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'MDLC', 'overall_survival_months': 159.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2853, 'age_at_diagnosis': 36.25, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'IMMC', 'overall_survival_months': 269.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2854, 'age_at_diagnosis': 61.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'ILC', 'overall_survival_months': 270.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2857, 'age_at_diagnosis': 45.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 250.6666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2858, 'age_at_diagnosis': 63.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'MDLC', 'overall_survival_months': 141.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2863, 'age_at_diagnosis': 59.58, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IMMC', 'overall_survival_months': 258.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2867, 'age_at_diagnosis': 47.1, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 269.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2895, 'age_at_diagnosis': 66.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 196.5666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2896, 'age_at_diagnosis': 68.18, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'IDC', 'overall_survival_months': 237.3666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2900, 'age_at_diagnosis': 59.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 9, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'ILC', 'overall_survival_months': 20.66666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2901, 'age_at_diagnosis': 49.83, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 218.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2904, 'age_at_diagnosis': 34.83, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 125.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2912, 'age_at_diagnosis': 59.6, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 267.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2916, 'age_at_diagnosis': 48.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.032, 'oncotree_code': 'IDC', 'overall_survival_months': 266.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2917, 'age_at_diagnosis': 33.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 31.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2919, 'age_at_diagnosis': 59.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IMMC', 'overall_survival_months': 240.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2922, 'age_at_diagnosis': 45.74, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'IDC', 'overall_survival_months': 14.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2923, 'age_at_diagnosis': 37.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.074, 'oncotree_code': 'IDC', 'overall_survival_months': 14.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2927, 'age_at_diagnosis': 58.14, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 2.026, 'oncotree_code': 'MDLC', 'overall_survival_months': 263.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2929, 'age_at_diagnosis': 53.31, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 262.8666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2931, 'age_at_diagnosis': 46.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 228.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2932, 'age_at_diagnosis': 63.1, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 108.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2933, 'age_at_diagnosis': 44.08, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'IDC', 'overall_survival_months': 161.9333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2939, 'age_at_diagnosis': 70.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.034, 'oncotree_code': 'IDC', 'overall_survival_months': 101.2666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2944, 'age_at_diagnosis': 66.97, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'MDLC', 'overall_survival_months': 27.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2947, 'age_at_diagnosis': 36.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 112.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2951, 'age_at_diagnosis': 39.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 263.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2952, 'age_at_diagnosis': 52.67, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 2.024, 'oncotree_code': 'IDC', 'overall_survival_months': 189.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2953, 'age_at_diagnosis': 43.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 30.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2954, 'age_at_diagnosis': 69.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 5.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2957, 'age_at_diagnosis': 31.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 262.1333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2960, 'age_at_diagnosis': 69.67, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 222.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 2963, 'age_at_diagnosis': 53.99, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.02, 'oncotree_code': 'MDLC', 'overall_survival_months': 227.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2964, 'age_at_diagnosis': 69.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'IDC', 'overall_survival_months': 9.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2966, 'age_at_diagnosis': 50.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 265.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2969, 'age_at_diagnosis': 66.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'IDC', 'overall_survival_months': 172.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2970, 'age_at_diagnosis': 46.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 252.8666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2971, 'age_at_diagnosis': 69.6, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 264.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2977, 'age_at_diagnosis': 40.02, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'IDC', 'overall_survival_months': 110.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2983, 'age_at_diagnosis': 56.26, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 180.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2984, 'age_at_diagnosis': 64.04, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 261.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2990, 'age_at_diagnosis': 48.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 260.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 2993, 'age_at_diagnosis': 63.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 187.0333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 2994, 'age_at_diagnosis': 46.7, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 254.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2996, 'age_at_diagnosis': 58.1, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 191.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 2999, 'age_at_diagnosis': 61.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.024, 'oncotree_code': 'IDC', 'overall_survival_months': 262.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3001, 'age_at_diagnosis': 50.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.024, 'oncotree_code': 'IDC', 'overall_survival_months': 263.2333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3002, 'age_at_diagnosis': 62.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'ILC', 'overall_survival_months': 140.5666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3005, 'age_at_diagnosis': 45.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'IDC', 'overall_survival_months': 253.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3006, 'age_at_diagnosis': 60.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 15.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3007, 'age_at_diagnosis': 48.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 114.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3008, 'age_at_diagnosis': 51.94, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.024, 'oncotree_code': 'MDLC', 'overall_survival_months': 149.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3013, 'age_at_diagnosis': 50.37, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'IDC', 'overall_survival_months': 238.3666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3014, 'age_at_diagnosis': 39.7, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 262.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3016, 'age_at_diagnosis': 56.83, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 258.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3021, 'age_at_diagnosis': 63.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'ILC', 'overall_survival_months': 217.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3025, 'age_at_diagnosis': 37.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.026, 'oncotree_code': 'IDC', 'overall_survival_months': 256.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3026, 'age_at_diagnosis': 49.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 261.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3028, 'age_at_diagnosis': 60.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 42.56666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3031, 'age_at_diagnosis': 46.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'IDC', 'overall_survival_months': 35.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3032, 'age_at_diagnosis': 50.01, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'IDC', 'overall_survival_months': 250.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3033, 'age_at_diagnosis': 69.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.038, 'oncotree_code': 'IDC', 'overall_survival_months': 70.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3035, 'age_at_diagnosis': 54.64, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IDC', 'overall_survival_months': 260.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3037, 'age_at_diagnosis': 53.19, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'MDLC', 'overall_survival_months': 98.83333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3046, 'age_at_diagnosis': 67.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 73.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3049, 'age_at_diagnosis': 57.17, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'ILC', 'overall_survival_months': 259.9666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3050, 'age_at_diagnosis': 59.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 255.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3057, 'age_at_diagnosis': 55.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.086, 'oncotree_code': 'IDC', 'overall_survival_months': 32.03333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3058, 'age_at_diagnosis': 47.74, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 254.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3060, 'age_at_diagnosis': 65.69, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.072, 'oncotree_code': 'IDC', 'overall_survival_months': 44.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3062, 'age_at_diagnosis': 62.87, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 146.3666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3063, 'age_at_diagnosis': 43.51, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 13.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 28.56666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3064, 'age_at_diagnosis': 46.7, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 165.1666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3067, 'age_at_diagnosis': 60.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 259.5333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3079, 'age_at_diagnosis': 50.54, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 149.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3083, 'age_at_diagnosis': 68.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 81.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3085, 'age_at_diagnosis': 43.68, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'ILC', 'overall_survival_months': 210.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3088, 'age_at_diagnosis': 65.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.038, 'oncotree_code': 'IDC', 'overall_survival_months': 256.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3092, 'age_at_diagnosis': 56.73, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.076, 'oncotree_code': 'MDLC', 'overall_survival_months': 152.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3102, 'age_at_diagnosis': 60.34, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 258.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3103, 'age_at_diagnosis': 58.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 28.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3104, 'age_at_diagnosis': 28.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 75.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3105, 'age_at_diagnosis': 48.34, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.054, 'oncotree_code': 'IDC', 'overall_survival_months': 252.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3110, 'age_at_diagnosis': 61.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'ILC', 'overall_survival_months': 100.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3121, 'age_at_diagnosis': 63.06, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.024, 'oncotree_code': 'IDC', 'overall_survival_months': 131.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3122, 'age_at_diagnosis': 62.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 257.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3123, 'age_at_diagnosis': 50.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.044, 'oncotree_code': 'IDC', 'overall_survival_months': 167.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3153, 'age_at_diagnosis': 42.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'IDC', 'overall_survival_months': 227.9333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3165, 'age_at_diagnosis': 59.78, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 221.2333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3167, 'age_at_diagnosis': 66.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 136.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3171, 'age_at_diagnosis': 54.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'IDC', 'overall_survival_months': 219.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3181, 'age_at_diagnosis': 43.6, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'IDC', 'overall_survival_months': 178.1666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3211, 'age_at_diagnosis': 58.31, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 145.5, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3218, 'age_at_diagnosis': 44.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.034, 'oncotree_code': 'IDC', 'overall_survival_months': 248.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3222, 'age_at_diagnosis': 63.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.034, 'oncotree_code': 'MDLC', 'overall_survival_months': 23.93333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3228, 'age_at_diagnosis': 58.31, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'MDLC', 'overall_survival_months': 252.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3235, 'age_at_diagnosis': 50.66, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 236.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3252, 'age_at_diagnosis': 41.4, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IMMC', 'overall_survival_months': 99.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3253, 'age_at_diagnosis': 56.81, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 16.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'IDC', 'overall_survival_months': 55.83333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3254, 'age_at_diagnosis': 50.21, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 2.036, 'oncotree_code': 'IDC', 'overall_survival_months': 123.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3266, 'age_at_diagnosis': 52.91, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.034, 'oncotree_code': 'MDLC', 'overall_survival_months': 51.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3271, 'age_at_diagnosis': 59.43, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 65.46666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3272, 'age_at_diagnosis': 63.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 22.66666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3275, 'age_at_diagnosis': 45.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'IDC', 'overall_survival_months': 41.53333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3277, 'age_at_diagnosis': 29.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 32.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3292, 'age_at_diagnosis': 60.04, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 217.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3295, 'age_at_diagnosis': 60.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 158.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3297, 'age_at_diagnosis': 42.72, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 14.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 236.0666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3298, 'age_at_diagnosis': 48.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 242.5666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3300, 'age_at_diagnosis': 64.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.038, 'oncotree_code': 'IDC', 'overall_survival_months': 247.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3301, 'age_at_diagnosis': 49.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.064, 'oncotree_code': 'IDC', 'overall_survival_months': 248.7666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3303, 'age_at_diagnosis': 63.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'BREAST', 'overall_survival_months': 243.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3328, 'age_at_diagnosis': 69.65, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 191.1333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3329, 'age_at_diagnosis': 56.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 37.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3341, 'age_at_diagnosis': 62.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 148.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3344, 'age_at_diagnosis': 33.76, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'IDC', 'overall_survival_months': 241.2666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3350, 'age_at_diagnosis': 62.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 227.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3351, 'age_at_diagnosis': 39.4, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 241.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3355, 'age_at_diagnosis': 48.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.054, 'oncotree_code': 'IDC', 'overall_survival_months': 109.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3357, 'age_at_diagnosis': 47.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 38.03333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3360, 'age_at_diagnosis': 48.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'IDC', 'overall_survival_months': 26.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3361, 'age_at_diagnosis': 57.31, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 68.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3363, 'age_at_diagnosis': 56.42, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 23.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 10.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3365, 'age_at_diagnosis': 51.18, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 241.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3367, 'age_at_diagnosis': 65.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 179.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3371, 'age_at_diagnosis': 66.15, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 241.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3378, 'age_at_diagnosis': 65.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'ILC', 'overall_survival_months': 87.53333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3379, 'age_at_diagnosis': 60.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'ILC', 'overall_survival_months': 113.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3381, 'age_at_diagnosis': 53.36, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 236.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3382, 'age_at_diagnosis': 61.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 136.2333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3383, 'age_at_diagnosis': 38.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 8, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.056, 'oncotree_code': 'IDC', 'overall_survival_months': 23.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3386, 'age_at_diagnosis': 40.06, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 55.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3388, 'age_at_diagnosis': 59.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 228.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3389, 'age_at_diagnosis': 63.34, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'ILC', 'overall_survival_months': 240.7, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3395, 'age_at_diagnosis': 52.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 243.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3396, 'age_at_diagnosis': 59.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 12.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 226.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3402, 'age_at_diagnosis': 41.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 50.03333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3403, 'age_at_diagnosis': 50.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 138.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3412, 'age_at_diagnosis': 55.28, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 7, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.052, 'oncotree_code': 'IDC', 'overall_survival_months': 228.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3417, 'age_at_diagnosis': 59.16, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 103.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3429, 'age_at_diagnosis': 49.08, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'ILC', 'overall_survival_months': 243.5, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3430, 'age_at_diagnosis': 68.86, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 219.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3435, 'age_at_diagnosis': 37.05, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 25.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3436, 'age_at_diagnosis': 38.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 6, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.26, 'oncotree_code': 'IDC', 'overall_survival_months': 50.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3437, 'age_at_diagnosis': 70.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 108.7666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3439, 'age_at_diagnosis': 43.67, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 16.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'MDLC', 'overall_survival_months': 188.7333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3450, 'age_at_diagnosis': 51.52, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 240.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3452, 'age_at_diagnosis': 64.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 119.8666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3453, 'age_at_diagnosis': 51.36, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 14.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 32.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3459, 'age_at_diagnosis': 57.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 241.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3462, 'age_at_diagnosis': 40.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 234.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3466, 'age_at_diagnosis': 55.3, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 234.1333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3467, 'age_at_diagnosis': 21.93, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'MDLC', 'overall_survival_months': 38.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3470, 'age_at_diagnosis': 56.4, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.11, 'oncotree_code': 'IDC', 'overall_survival_months': 62.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3476, 'age_at_diagnosis': 68.59, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 159.0666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3479, 'age_at_diagnosis': 60.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 231.6666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3487, 'age_at_diagnosis': 43.58, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 237.1333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3488, 'age_at_diagnosis': 41.1, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 27.46666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3490, 'age_at_diagnosis': 45.74, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 18.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 102.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3492, 'age_at_diagnosis': 62.09, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 118.1333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3497, 'age_at_diagnosis': 53.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.062, 'oncotree_code': 'IDC', 'overall_survival_months': 15.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3500, 'age_at_diagnosis': 66.91, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 239.3, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3502, 'age_at_diagnosis': 50.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.054, 'oncotree_code': 'IDC', 'overall_survival_months': 229.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3506, 'age_at_diagnosis': 39.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'BREAST', 'overall_survival_months': 240.8333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3510, 'age_at_diagnosis': 67.6, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 59.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3525, 'age_at_diagnosis': 65.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 26.0, 'nottingham_prognostic_index': 6.054, 'oncotree_code': 'IDC', 'overall_survival_months': 236.7, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3526, 'age_at_diagnosis': 60.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 86.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3528, 'age_at_diagnosis': 71.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 113.6666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3530, 'age_at_diagnosis': 70.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 20.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'MDLC', 'overall_survival_months': 112.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3536, 'age_at_diagnosis': 48.12, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'UNDEF', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 86.23333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3545, 'age_at_diagnosis': 49.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 232.7333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3548, 'age_at_diagnosis': 66.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 234.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3556, 'age_at_diagnosis': 51.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.16, 'oncotree_code': 'IDC', 'overall_survival_months': 38.03333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3567, 'age_at_diagnosis': 55.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 236.0333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3576, 'age_at_diagnosis': 53.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.074, 'oncotree_code': 'MDLC', 'overall_survival_months': 24.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3582, 'age_at_diagnosis': 63.97, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 1.12, 'oncotree_code': 'IDC', 'overall_survival_months': 229.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3600, 'age_at_diagnosis': 60.15, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.024, 'oncotree_code': 'IDC', 'overall_survival_months': 214.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3606, 'age_at_diagnosis': 68.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 110.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3614, 'age_at_diagnosis': 63.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.068, 'oncotree_code': 'IDC', 'overall_survival_months': 235.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3702, 'age_at_diagnosis': 37.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.011, 'oncotree_code': 'IDC', 'overall_survival_months': 230.4666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3706, 'age_at_diagnosis': 55.71, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 38.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3707, 'age_at_diagnosis': 70.77, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 228.7666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3711, 'age_at_diagnosis': 41.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 222.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3748, 'age_at_diagnosis': 51.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 228.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3752, 'age_at_diagnosis': 49.98, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 75.33333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3754, 'age_at_diagnosis': 57.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 92.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 3781, 'age_at_diagnosis': 48.16, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'MDLC', 'overall_survival_months': 224.5666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3797, 'age_at_diagnosis': 68.72, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 1.048, 'oncotree_code': 'BREAST', 'overall_survival_months': 228.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3824, 'age_at_diagnosis': 49.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 126.4666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3838, 'age_at_diagnosis': 60.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 134.4666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3840, 'age_at_diagnosis': 53.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 287.2333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3842, 'age_at_diagnosis': 54.6, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.048, 'oncotree_code': 'IDC', 'overall_survival_months': 226.0666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3850, 'age_at_diagnosis': 65.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 72.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3852, 'age_at_diagnosis': 43.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 225.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3854, 'age_at_diagnosis': 63.82, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 2.024, 'oncotree_code': 'MDLC', 'overall_survival_months': 99.23333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3865, 'age_at_diagnosis': 49.37, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'IDC', 'overall_survival_months': 199.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3866, 'age_at_diagnosis': 54.29, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.024, 'oncotree_code': 'IDC', 'overall_survival_months': 225.5, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 3871, 'age_at_diagnosis': 62.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'IDC', 'overall_survival_months': 172.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 3874, 'age_at_diagnosis': 35.5, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 2, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 186.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 3978, 'age_at_diagnosis': 57.91, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 2, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 100.8666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4000, 'age_at_diagnosis': 76.96, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 28.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4001, 'age_at_diagnosis': 74.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'IDC', 'overall_survival_months': 49.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4003, 'age_at_diagnosis': 70.31, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 106.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4004, 'age_at_diagnosis': 61.16, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 256.8666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4005, 'age_at_diagnosis': 66.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'ILC', 'overall_survival_months': 188.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4008, 'age_at_diagnosis': 64.91, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 44.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4010, 'age_at_diagnosis': 73.15, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 11.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4011, 'age_at_diagnosis': 72.36, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'UNDEF', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 193.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4012, 'age_at_diagnosis': 63.23, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 277.3666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4015, 'age_at_diagnosis': 76.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 11.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4017, 'age_at_diagnosis': 76.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'MDLC', 'overall_survival_months': 139.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4018, 'age_at_diagnosis': 71.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 10, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 105.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4024, 'age_at_diagnosis': 56.14, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 124.1, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4033, 'age_at_diagnosis': 82.17, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'ILC', 'overall_survival_months': 15.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4046, 'age_at_diagnosis': 59.24, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'MDLC', 'overall_survival_months': 298.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4059, 'age_at_diagnosis': 50.23, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 172.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4079, 'age_at_diagnosis': 63.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 24.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 351.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4091, 'age_at_diagnosis': 74.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 281.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4098, 'age_at_diagnosis': 68.55, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.1, 'oncotree_code': 'IDC', 'overall_survival_months': 176.3666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4119, 'age_at_diagnosis': 65.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 67.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4120, 'age_at_diagnosis': 56.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'IDC', 'overall_survival_months': 217.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4126, 'age_at_diagnosis': 73.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 1.06, 'oncotree_code': 'IDC', 'overall_survival_months': 174.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4127, 'age_at_diagnosis': 54.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'IDC', 'overall_survival_months': 258.1666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4139, 'age_at_diagnosis': 63.05, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 165.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4140, 'age_at_diagnosis': 71.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 114.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4141, 'age_at_diagnosis': 58.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 147.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4145, 'age_at_diagnosis': 60.33, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 1.04, 'oncotree_code': 'IDC', 'overall_survival_months': 217.6333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4146, 'age_at_diagnosis': 43.06, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 13, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 15.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4148, 'age_at_diagnosis': 57.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 16, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 63.03333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4154, 'age_at_diagnosis': 54.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 49.56666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4171, 'age_at_diagnosis': 64.21, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.086, 'oncotree_code': 'MDLC', 'overall_survival_months': 184.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4173, 'age_at_diagnosis': 74.31, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 160.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4189, 'age_at_diagnosis': 60.99, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.0, 'oncotree_code': 'IDC', 'overall_survival_months': 355.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4212, 'age_at_diagnosis': 45.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 330.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4213, 'age_at_diagnosis': 67.02, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 84.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4222, 'age_at_diagnosis': 58.8, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.08, 'oncotree_code': 'IDC', 'overall_survival_months': 55.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4224, 'age_at_diagnosis': 72.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'NC', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 65.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4230, 'age_at_diagnosis': 75.87, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.1, 'oncotree_code': 'IDC', 'overall_survival_months': 115.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4233, 'age_at_diagnosis': 54.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 11.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 36.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4234, 'age_at_diagnosis': 68.25, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 253.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4235, 'age_at_diagnosis': 67.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 335.7333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4236, 'age_at_diagnosis': 73.91, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 203.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4250, 'age_at_diagnosis': 80.81, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.11, 'oncotree_code': 'IDC', 'overall_survival_months': 100.1666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4254, 'age_at_diagnosis': 68.7, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 178.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4264, 'age_at_diagnosis': 72.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 163.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4266, 'age_at_diagnosis': 28.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.09, 'oncotree_code': 'IDC', 'overall_survival_months': 33.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4270, 'age_at_diagnosis': 37.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 98.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4274, 'age_at_diagnosis': 74.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 59.93333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4276, 'age_at_diagnosis': 55.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 132.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4278, 'age_at_diagnosis': 68.32, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 14.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 244.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4281, 'age_at_diagnosis': 60.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.046, 'oncotree_code': 'IDC', 'overall_survival_months': 260.0333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4282, 'age_at_diagnosis': 49.61, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 34.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4283, 'age_at_diagnosis': 55.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 174.8333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4289, 'age_at_diagnosis': 65.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'ILC', 'overall_survival_months': 96.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4292, 'age_at_diagnosis': 58.8, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 335.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4293, 'age_at_diagnosis': 54.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 219.1666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4300, 'age_at_diagnosis': 70.58, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 189.0333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4303, 'age_at_diagnosis': 66.91, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 89.03333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4306, 'age_at_diagnosis': 69.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.042, 'oncotree_code': 'MDLC', 'overall_survival_months': 234.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4310, 'age_at_diagnosis': 76.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.1, 'oncotree_code': 'IDC', 'overall_survival_months': 265.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4313, 'age_at_diagnosis': 58.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 10.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'MDLC', 'overall_survival_months': 300.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4317, 'age_at_diagnosis': 51.93, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.1, 'oncotree_code': 'IDC', 'overall_survival_months': 177.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4318, 'age_at_diagnosis': 72.44, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 17.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4322, 'age_at_diagnosis': 63.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 196.4666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4323, 'age_at_diagnosis': 80.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 126.6333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4324, 'age_at_diagnosis': 61.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 24, 'mutation_count': 10.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 87.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4328, 'age_at_diagnosis': 64.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 199.2666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4329, 'age_at_diagnosis': 70.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.058, 'oncotree_code': 'IDC', 'overall_survival_months': 168.2666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4331, 'age_at_diagnosis': 63.34, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 235.5666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4332, 'age_at_diagnosis': 34.36, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 307.9333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4333, 'age_at_diagnosis': 64.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.05, 'oncotree_code': 'IDC', 'overall_survival_months': 207.9666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4339, 'age_at_diagnosis': 74.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 173.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4341, 'age_at_diagnosis': 35.14, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 18, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'IDC', 'overall_survival_months': 33.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4342, 'age_at_diagnosis': 73.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.124, 'oncotree_code': 'IDC', 'overall_survival_months': 232.7666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4343, 'age_at_diagnosis': 68.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 14.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 198.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4348, 'age_at_diagnosis': 61.57, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'IDC', 'overall_survival_months': 226.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4350, 'age_at_diagnosis': 35.64, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 31.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4351, 'age_at_diagnosis': 70.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 68.13333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4353, 'age_at_diagnosis': 59.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 128.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4354, 'age_at_diagnosis': 55.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 15.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4357, 'age_at_diagnosis': 77.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 17.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 114.0333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4360, 'age_at_diagnosis': 59.16, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.016, 'oncotree_code': 'IDC', 'overall_survival_months': 11.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4362, 'age_at_diagnosis': 50.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 267.2666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4368, 'age_at_diagnosis': 74.6, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 119.4666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4374, 'age_at_diagnosis': 77.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 42.56666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4375, 'age_at_diagnosis': 40.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 291.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4381, 'age_at_diagnosis': 59.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 61.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4390, 'age_at_diagnosis': 68.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 164.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4395, 'age_at_diagnosis': 45.21, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 139.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4407, 'age_at_diagnosis': 44.4, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 83.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4408, 'age_at_diagnosis': 71.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 206.5666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4416, 'age_at_diagnosis': 44.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 241.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4417, 'age_at_diagnosis': 68.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.064, 'oncotree_code': 'IDC', 'overall_survival_months': 16.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4418, 'age_at_diagnosis': 56.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 307.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4421, 'age_at_diagnosis': 69.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'IDC', 'overall_survival_months': 264.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4426, 'age_at_diagnosis': 70.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.09, 'oncotree_code': 'IDC', 'overall_survival_months': 170.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4434, 'age_at_diagnosis': 74.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 148.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4442, 'age_at_diagnosis': 47.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 296.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4484, 'age_at_diagnosis': 66.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.11, 'oncotree_code': 'MDLC', 'overall_survival_months': 52.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4529, 'age_at_diagnosis': 61.21, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'IDC', 'overall_survival_months': 126.4666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4548, 'age_at_diagnosis': 50.42, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.002, 'oncotree_code': 'IDC', 'overall_survival_months': 322.8333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4557, 'age_at_diagnosis': 51.25, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 279.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4564, 'age_at_diagnosis': 74.67, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.036, 'oncotree_code': 'IDC', 'overall_survival_months': 210.4333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4578, 'age_at_diagnosis': 72.74, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.09, 'oncotree_code': 'IDC', 'overall_survival_months': 197.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4591, 'age_at_diagnosis': 71.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 41.16666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4593, 'age_at_diagnosis': 48.44, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 140.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4598, 'age_at_diagnosis': 67.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 119.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4599, 'age_at_diagnosis': 63.83, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 191.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4601, 'age_at_diagnosis': 39.14, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 56.26666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4602, 'age_at_diagnosis': 58.38, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 122.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4603, 'age_at_diagnosis': 42.79, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 239.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4607, 'age_at_diagnosis': 55.42, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 121.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4616, 'age_at_diagnosis': 71.47, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 90.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4618, 'age_at_diagnosis': 40.05, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'MDLC', 'overall_survival_months': 267.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4621, 'age_at_diagnosis': 39.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.106, 'oncotree_code': 'IDC', 'overall_survival_months': 271.8666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4622, 'age_at_diagnosis': 40.83, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.1, 'oncotree_code': 'IDC', 'overall_survival_months': 282.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4623, 'age_at_diagnosis': 61.88, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.02, 'oncotree_code': 'MDLC', 'overall_survival_months': 292.0333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4626, 'age_at_diagnosis': 64.61, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 143.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4627, 'age_at_diagnosis': 55.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 9, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 186.6333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4630, 'age_at_diagnosis': 67.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.07, 'oncotree_code': 'IDC', 'overall_survival_months': 95.83333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4633, 'age_at_diagnosis': 67.03, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 318.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4634, 'age_at_diagnosis': 66.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 109.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4639, 'age_at_diagnosis': 71.17, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 119.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4640, 'age_at_diagnosis': 61.59, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 200.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4641, 'age_at_diagnosis': 64.93, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 148.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4642, 'age_at_diagnosis': 66.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 285.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4643, 'age_at_diagnosis': 78.21, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 41.46666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4644, 'age_at_diagnosis': 59.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 90.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4648, 'age_at_diagnosis': 75.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 168.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4649, 'age_at_diagnosis': 61.67, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 15.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 16.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4651, 'age_at_diagnosis': 69.96, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.07, 'oncotree_code': 'IDC', 'overall_survival_months': 30.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4653, 'age_at_diagnosis': 44.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.062, 'oncotree_code': 'IDC', 'overall_survival_months': 48.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4654, 'age_at_diagnosis': 80.82, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 64.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4655, 'age_at_diagnosis': 64.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'IDC', 'overall_survival_months': 99.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4660, 'age_at_diagnosis': 37.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 14, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.056, 'oncotree_code': 'IDC', 'overall_survival_months': 39.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4661, 'age_at_diagnosis': 81.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 234.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4663, 'age_at_diagnosis': 61.97, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 239.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4665, 'age_at_diagnosis': 54.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 260.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4666, 'age_at_diagnosis': 57.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 9, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.03, 'oncotree_code': 'IDC', 'overall_survival_months': 111.5666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4667, 'age_at_diagnosis': 65.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 40.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'ILC', 'overall_survival_months': 295.3333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4669, 'age_at_diagnosis': 68.82, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 119.4666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4670, 'age_at_diagnosis': 61.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 67.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4671, 'age_at_diagnosis': 72.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 34.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4672, 'age_at_diagnosis': 58.78, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 220.9333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4673, 'age_at_diagnosis': 63.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 87.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4674, 'age_at_diagnosis': 75.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 81.06666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4675, 'age_at_diagnosis': 59.23, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 263.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4679, 'age_at_diagnosis': 64.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 292.6666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4681, 'age_at_diagnosis': 60.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 1.034, 'oncotree_code': 'IDC', 'overall_survival_months': 251.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4682, 'age_at_diagnosis': 65.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 139.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4685, 'age_at_diagnosis': 73.6, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 43.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4686, 'age_at_diagnosis': 53.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 48.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4687, 'age_at_diagnosis': 81.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 74.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4688, 'age_at_diagnosis': 71.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 9, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.09, 'oncotree_code': 'IDC', 'overall_survival_months': 85.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4691, 'age_at_diagnosis': 49.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 16.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 282.5666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4692, 'age_at_diagnosis': 58.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.05, 'oncotree_code': 'IDC', 'overall_survival_months': 107.2666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4694, 'age_at_diagnosis': 76.06, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 198.3, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4695, 'age_at_diagnosis': 61.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'ILC', 'overall_survival_months': 21.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4696, 'age_at_diagnosis': 49.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.09, 'oncotree_code': 'IDC', 'overall_survival_months': 255.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4697, 'age_at_diagnosis': 79.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'NC', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 1.06, 'oncotree_code': 'ILC', 'overall_survival_months': 118.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4698, 'age_at_diagnosis': 59.18, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'ILC', 'overall_survival_months': 170.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4701, 'age_at_diagnosis': 47.62, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 127.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4702, 'age_at_diagnosis': 52.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 300.8666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4704, 'age_at_diagnosis': 67.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.098, 'oncotree_code': 'MDLC', 'overall_survival_months': 64.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4705, 'age_at_diagnosis': 63.58, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.054, 'oncotree_code': 'IDC', 'overall_survival_months': 213.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4706, 'age_at_diagnosis': 75.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 55.66666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4707, 'age_at_diagnosis': 59.85, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 221.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4708, 'age_at_diagnosis': 63.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'ILC', 'overall_survival_months': 227.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4709, 'age_at_diagnosis': 49.02, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 146.7666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4710, 'age_at_diagnosis': 77.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.038, 'oncotree_code': 'IDC', 'overall_survival_months': 57.66666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4711, 'age_at_diagnosis': 56.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 11, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.198, 'oncotree_code': 'IDC', 'overall_survival_months': 31.46666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4712, 'age_at_diagnosis': 46.59, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 249.5333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4714, 'age_at_diagnosis': 64.68, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 11, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.002, 'oncotree_code': 'IDC', 'overall_survival_months': 83.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4715, 'age_at_diagnosis': 67.8, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.09, 'oncotree_code': 'IDC', 'overall_survival_months': 35.23333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4716, 'age_at_diagnosis': 52.98, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'ILC', 'overall_survival_months': 76.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4717, 'age_at_diagnosis': 43.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 42.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4718, 'age_at_diagnosis': 44.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.198, 'oncotree_code': 'ILC', 'overall_survival_months': 198.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4719, 'age_at_diagnosis': 67.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 81.56666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4721, 'age_at_diagnosis': 66.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.12, 'oncotree_code': 'ILC', 'overall_survival_months': 23.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4722, 'age_at_diagnosis': 64.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 86.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4723, 'age_at_diagnosis': 64.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 211.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4724, 'age_at_diagnosis': 60.44, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 146.0666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4725, 'age_at_diagnosis': 65.83, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'IDC', 'overall_survival_months': 98.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4729, 'age_at_diagnosis': 75.41, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 28.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4730, 'age_at_diagnosis': 51.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.136, 'oncotree_code': 'MDLC', 'overall_survival_months': 131.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4731, 'age_at_diagnosis': 49.43, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.12, 'oncotree_code': 'IDC', 'overall_survival_months': 44.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4732, 'age_at_diagnosis': 26.72, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.09, 'oncotree_code': 'IDC', 'overall_survival_months': 149.8666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4733, 'age_at_diagnosis': 56.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.036, 'oncotree_code': 'IDC', 'overall_survival_months': 19.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4735, 'age_at_diagnosis': 54.18, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'IDC', 'overall_survival_months': 297.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4737, 'age_at_diagnosis': 52.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.092, 'oncotree_code': 'IDC', 'overall_survival_months': 122.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4738, 'age_at_diagnosis': 42.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 176.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4739, 'age_at_diagnosis': 56.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 161.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4741, 'age_at_diagnosis': 53.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'ILC', 'overall_survival_months': 56.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4742, 'age_at_diagnosis': 76.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.07, 'oncotree_code': 'MDLC', 'overall_survival_months': 83.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4743, 'age_at_diagnosis': 52.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 230.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4744, 'age_at_diagnosis': 64.21, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'IDC', 'overall_survival_months': 153.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4745, 'age_at_diagnosis': 50.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 15.0, 'nottingham_prognostic_index': 5.074, 'oncotree_code': 'IDC', 'overall_survival_months': 42.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4746, 'age_at_diagnosis': 38.1, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 15.0, 'nottingham_prognostic_index': 5.09, 'oncotree_code': 'IDC', 'overall_survival_months': 244.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4749, 'age_at_diagnosis': 70.57, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 14.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'MDLC', 'overall_survival_months': 51.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4750, 'age_at_diagnosis': 73.21, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 37.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4752, 'age_at_diagnosis': 63.7, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.12, 'oncotree_code': 'IDC', 'overall_survival_months': 125.2666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4757, 'age_at_diagnosis': 38.93, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.02, 'oncotree_code': 'IDC', 'overall_survival_months': 27.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4758, 'age_at_diagnosis': 45.77, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 211.9333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4760, 'age_at_diagnosis': 48.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'IDC', 'overall_survival_months': 124.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4762, 'age_at_diagnosis': 67.82, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 252.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4763, 'age_at_diagnosis': 44.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 102.1, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4764, 'age_at_diagnosis': 57.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'ILC', 'overall_survival_months': 245.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4767, 'age_at_diagnosis': 74.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 47.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4769, 'age_at_diagnosis': 65.86, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 21.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4770, 'age_at_diagnosis': 70.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 152.0666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4771, 'age_at_diagnosis': 47.86, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 297.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4778, 'age_at_diagnosis': 78.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 206.1333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4779, 'age_at_diagnosis': 53.39, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 101.5666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4782, 'age_at_diagnosis': 43.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.0, 'oncotree_code': 'IDC', 'overall_survival_months': 251.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4784, 'age_at_diagnosis': 63.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 145.7333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4785, 'age_at_diagnosis': 75.46, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.056, 'oncotree_code': 'IDC', 'overall_survival_months': 121.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4787, 'age_at_diagnosis': 68.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 81.06666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4790, 'age_at_diagnosis': 43.73, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.056, 'oncotree_code': 'IDC', 'overall_survival_months': 70.46666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4791, 'age_at_diagnosis': 83.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 46.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 173.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4792, 'age_at_diagnosis': 49.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 40.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4793, 'age_at_diagnosis': 72.49, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 83.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4794, 'age_at_diagnosis': 89.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.07, 'oncotree_code': 'IDC', 'overall_survival_months': 45.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4796, 'age_at_diagnosis': 53.18, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 128.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4797, 'age_at_diagnosis': 81.06, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'ILC', 'overall_survival_months': 99.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4798, 'age_at_diagnosis': 44.51, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'ILC', 'overall_survival_months': 257.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4800, 'age_at_diagnosis': 61.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 110.9333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4801, 'age_at_diagnosis': 65.83, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 7, 'mutation_count': 12.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 130.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4802, 'age_at_diagnosis': 71.67, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'IDC', 'overall_survival_months': 43.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4805, 'age_at_diagnosis': 45.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 129.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4806, 'age_at_diagnosis': 49.77, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 201.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4809, 'age_at_diagnosis': 43.77, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'IDC', 'overall_survival_months': 286.0666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4814, 'age_at_diagnosis': 39.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.1, 'oncotree_code': 'IDC', 'overall_survival_months': 73.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4818, 'age_at_diagnosis': 75.74, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.114, 'oncotree_code': 'MDLC', 'overall_survival_months': 76.23333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4820, 'age_at_diagnosis': 67.19, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.032, 'oncotree_code': 'IDC', 'overall_survival_months': 57.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4822, 'age_at_diagnosis': 76.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'MDLC', 'overall_survival_months': 91.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4825, 'age_at_diagnosis': 65.93, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'IDC', 'overall_survival_months': 214.4333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4827, 'age_at_diagnosis': 78.54, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IDC', 'overall_survival_months': 45.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4828, 'age_at_diagnosis': 78.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.16, 'oncotree_code': 'ILC', 'overall_survival_months': 42.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4829, 'age_at_diagnosis': 83.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.02, 'oncotree_code': 'MDLC', 'overall_survival_months': 176.2666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4832, 'age_at_diagnosis': 45.44, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.022, 'oncotree_code': 'IDC', 'overall_survival_months': 141.7333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4834, 'age_at_diagnosis': 49.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 11.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 36.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4836, 'age_at_diagnosis': 55.66, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 23.43333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4838, 'age_at_diagnosis': 74.39, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.198, 'oncotree_code': 'IDC', 'overall_survival_months': 200.7666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4839, 'age_at_diagnosis': 67.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 1.024, 'oncotree_code': 'IDC', 'overall_survival_months': 299.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4843, 'age_at_diagnosis': 54.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 2.06, 'oncotree_code': 'IDC', 'overall_survival_months': 265.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4845, 'age_at_diagnosis': 86.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 19, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 25.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4846, 'age_at_diagnosis': 63.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'ILC', 'overall_survival_months': 101.6333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4849, 'age_at_diagnosis': 81.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 45.33333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4851, 'age_at_diagnosis': 73.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 90.26666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4853, 'age_at_diagnosis': 62.35, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'ILC', 'overall_survival_months': 265.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4855, 'age_at_diagnosis': 74.8, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 41.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4858, 'age_at_diagnosis': 74.56, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 129.3333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4859, 'age_at_diagnosis': 74.29, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 157.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4860, 'age_at_diagnosis': 44.95, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'ILC', 'overall_survival_months': 234.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4862, 'age_at_diagnosis': 64.32, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 187.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4865, 'age_at_diagnosis': 50.7, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 229.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4866, 'age_at_diagnosis': 43.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 224.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4867, 'age_at_diagnosis': 47.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 221.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4869, 'age_at_diagnosis': 67.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 29.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4870, 'age_at_diagnosis': 57.33, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.05, 'oncotree_code': 'IDC', 'overall_survival_months': 229.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4871, 'age_at_diagnosis': 74.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'IDC', 'overall_survival_months': 39.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4872, 'age_at_diagnosis': 58.69, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'ILC', 'overall_survival_months': 157.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4873, 'age_at_diagnosis': 64.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 14, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 117.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4876, 'age_at_diagnosis': 42.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.056, 'oncotree_code': 'ILC', 'overall_survival_months': 150.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4878, 'age_at_diagnosis': 79.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 22.46666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4879, 'age_at_diagnosis': 49.34, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 79.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4880, 'age_at_diagnosis': 69.68, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 210.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4881, 'age_at_diagnosis': 37.05, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 274.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4882, 'age_at_diagnosis': 76.71, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.014, 'oncotree_code': 'IDC', 'overall_survival_months': 266.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4883, 'age_at_diagnosis': 57.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 268.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4886, 'age_at_diagnosis': 43.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 13.0, 'nottingham_prognostic_index': 5.09, 'oncotree_code': 'IDC', 'overall_survival_months': 48.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4887, 'age_at_diagnosis': 52.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 11.0, 'nottingham_prognostic_index': 5.066, 'oncotree_code': 'IDC', 'overall_survival_months': 35.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4888, 'age_at_diagnosis': 63.95, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 230.5, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4893, 'age_at_diagnosis': 33.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 176.7, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4894, 'age_at_diagnosis': 47.71, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 232.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4896, 'age_at_diagnosis': 41.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 64.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4897, 'age_at_diagnosis': 40.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.002, 'oncotree_code': 'MDLC', 'overall_survival_months': 197.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4898, 'age_at_diagnosis': 63.63, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'IDC', 'overall_survival_months': 117.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4899, 'age_at_diagnosis': 40.25, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 275.7333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4900, 'age_at_diagnosis': 47.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 224.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4904, 'age_at_diagnosis': 64.3, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.0, 'oncotree_code': 'IDC', 'overall_survival_months': 129.2333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4906, 'age_at_diagnosis': 73.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'IDC', 'overall_survival_months': 233.8666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4908, 'age_at_diagnosis': 69.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 47.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4911, 'age_at_diagnosis': 43.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 31.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4912, 'age_at_diagnosis': 78.19, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'IDC', 'overall_survival_months': 50.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4925, 'age_at_diagnosis': 76.54, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 102.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4928, 'age_at_diagnosis': 75.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 10.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 220.0333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4929, 'age_at_diagnosis': 59.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 10.0, 'nottingham_prognostic_index': 6.052, 'oncotree_code': 'IDC', 'overall_survival_months': 40.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4930, 'age_at_diagnosis': 62.43, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 58.43333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4931, 'age_at_diagnosis': 58.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 30.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4933, 'age_at_diagnosis': 50.78, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 272.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4934, 'age_at_diagnosis': 74.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 10.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 70.23333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4935, 'age_at_diagnosis': 36.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.046, 'oncotree_code': 'IDC', 'overall_survival_months': 194.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4937, 'age_at_diagnosis': 41.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 77.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4938, 'age_at_diagnosis': 33.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 30.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 70.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4941, 'age_at_diagnosis': 57.32, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 58.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4942, 'age_at_diagnosis': 60.31, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 124.1333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4944, 'age_at_diagnosis': 77.77, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 237.2666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4945, 'age_at_diagnosis': 65.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.038, 'oncotree_code': 'IDC', 'overall_survival_months': 20.13333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4949, 'age_at_diagnosis': 69.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 16.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 216.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4950, 'age_at_diagnosis': 69.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 12, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'IDC', 'overall_survival_months': 150.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4952, 'age_at_diagnosis': 67.15, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 184.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4956, 'age_at_diagnosis': 69.31, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.12, 'oncotree_code': 'IDC', 'overall_survival_months': 69.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4957, 'age_at_diagnosis': 70.38, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 197.6666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4959, 'age_at_diagnosis': 76.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 2.026, 'oncotree_code': 'IDC', 'overall_survival_months': 117.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4961, 'age_at_diagnosis': 56.94, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 219.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4962, 'age_at_diagnosis': 72.44, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'IDC', 'overall_survival_months': 197.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4965, 'age_at_diagnosis': 69.93, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 263.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4966, 'age_at_diagnosis': 55.83, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'MDLC', 'overall_survival_months': 49.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4967, 'age_at_diagnosis': 61.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 130.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4968, 'age_at_diagnosis': 56.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'ILC', 'overall_survival_months': 78.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4969, 'age_at_diagnosis': 76.81, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 17.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 198.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4970, 'age_at_diagnosis': 77.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 88.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4974, 'age_at_diagnosis': 65.16, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 176.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4976, 'age_at_diagnosis': 73.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 224.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4977, 'age_at_diagnosis': 72.54, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.044, 'oncotree_code': 'IDC', 'overall_survival_months': 216.7333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4978, 'age_at_diagnosis': 58.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'ILC', 'overall_survival_months': 198.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4981, 'age_at_diagnosis': 69.67, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 180.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4982, 'age_at_diagnosis': 62.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.034, 'oncotree_code': 'IDC', 'overall_survival_months': 19.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4986, 'age_at_diagnosis': 41.0, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.1, 'oncotree_code': 'IDC', 'overall_survival_months': 79.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4987, 'age_at_diagnosis': 76.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 221.7666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4991, 'age_at_diagnosis': 77.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 126.8666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4992, 'age_at_diagnosis': 66.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.066, 'oncotree_code': 'ILC', 'overall_survival_months': 165.3666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4993, 'age_at_diagnosis': 33.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 15.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 75.23333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 4994, 'age_at_diagnosis': 77.54, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IDC', 'overall_survival_months': 174.1333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 4996, 'age_at_diagnosis': 69.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 99.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 4998, 'age_at_diagnosis': 75.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 10.0, 'nottingham_prognostic_index': 6.064, 'oncotree_code': 'ILC', 'overall_survival_months': 65.56666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 4999, 'age_at_diagnosis': 44.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 187.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5001, 'age_at_diagnosis': 71.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 81.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5004, 'age_at_diagnosis': 42.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 17.0, 'nottingham_prognostic_index': 5.074, 'oncotree_code': 'IDC', 'overall_survival_months': 216.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5008, 'age_at_diagnosis': 65.76, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.12, 'oncotree_code': 'IDC', 'overall_survival_months': 223.3, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5011, 'age_at_diagnosis': 67.68, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'MDLC', 'overall_survival_months': 80.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5013, 'age_at_diagnosis': 68.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 251.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5014, 'age_at_diagnosis': 69.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 213.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5015, 'age_at_diagnosis': 44.36, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 252.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5017, 'age_at_diagnosis': 65.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.028, 'oncotree_code': 'IDC', 'overall_survival_months': 144.9333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5018, 'age_at_diagnosis': 72.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 108.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5019, 'age_at_diagnosis': 49.88, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.024, 'oncotree_code': 'IDC', 'overall_survival_months': 37.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5020, 'age_at_diagnosis': 62.68, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.034, 'oncotree_code': 'MDLC', 'overall_survival_months': 84.83333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5027, 'age_at_diagnosis': 46.95, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 189.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5033, 'age_at_diagnosis': 63.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 2.086, 'oncotree_code': 'IMMC', 'overall_survival_months': 52.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5035, 'age_at_diagnosis': 56.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 19.0, 'nottingham_prognostic_index': 4.11, 'oncotree_code': 'MDLC', 'overall_survival_months': 213.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5039, 'age_at_diagnosis': 67.7, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.11, 'oncotree_code': 'IDC', 'overall_survival_months': 62.13333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5040, 'age_at_diagnosis': 72.73, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 79.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5041, 'age_at_diagnosis': 45.4, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 173.9333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5043, 'age_at_diagnosis': 70.42, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'MDLC', 'overall_survival_months': 128.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5044, 'age_at_diagnosis': 55.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 139.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5045, 'age_at_diagnosis': 70.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 168.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5048, 'age_at_diagnosis': 44.12, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 86.36666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5049, 'age_at_diagnosis': 61.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'MDLC', 'overall_survival_months': 255.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5050, 'age_at_diagnosis': 55.04, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 184.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5052, 'age_at_diagnosis': 76.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 34.56666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5053, 'age_at_diagnosis': 68.21, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.042, 'oncotree_code': 'IDC', 'overall_survival_months': 150.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5054, 'age_at_diagnosis': 52.57, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.002, 'oncotree_code': 'IDC', 'overall_survival_months': 187.7, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5057, 'age_at_diagnosis': 39.25, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 56.33333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5058, 'age_at_diagnosis': 61.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 16, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 178.7333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5059, 'age_at_diagnosis': 53.69, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'MDLC', 'overall_survival_months': 257.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5060, 'age_at_diagnosis': 75.01, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 150.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5061, 'age_at_diagnosis': 71.05, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 39.43333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5062, 'age_at_diagnosis': 75.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 168.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5063, 'age_at_diagnosis': 41.54, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 215.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5064, 'age_at_diagnosis': 63.4, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 91.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5065, 'age_at_diagnosis': 68.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'MDLC', 'overall_survival_months': 184.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5066, 'age_at_diagnosis': 53.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 94.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5068, 'age_at_diagnosis': 71.19, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 182.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5070, 'age_at_diagnosis': 47.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 213.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5072, 'age_at_diagnosis': 52.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 12.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 50.23333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5073, 'age_at_diagnosis': 67.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.1, 'oncotree_code': 'IDC', 'overall_survival_months': 194.1666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5074, 'age_at_diagnosis': 70.59, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'ILC', 'overall_survival_months': 221.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5078, 'age_at_diagnosis': 56.33, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.048, 'oncotree_code': 'IDC', 'overall_survival_months': 87.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5079, 'age_at_diagnosis': 66.38, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 199.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5081, 'age_at_diagnosis': 43.63, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 58.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5084, 'age_at_diagnosis': 49.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 198.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5086, 'age_at_diagnosis': 65.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.02, 'oncotree_code': 'IDC', 'overall_survival_months': 84.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5088, 'age_at_diagnosis': 72.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 199.3666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5092, 'age_at_diagnosis': 76.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 174.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5093, 'age_at_diagnosis': 69.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 142.4333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5097, 'age_at_diagnosis': 56.33, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IDC', 'overall_survival_months': 61.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5098, 'age_at_diagnosis': 61.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 186.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5100, 'age_at_diagnosis': 32.74, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 17, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 19.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5101, 'age_at_diagnosis': 67.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 14, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.1, 'oncotree_code': 'IDC', 'overall_survival_months': 34.33333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5102, 'age_at_diagnosis': 69.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 20, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 30.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5105, 'age_at_diagnosis': 63.24, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.022, 'oncotree_code': 'IDC', 'overall_survival_months': 204.4333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5107, 'age_at_diagnosis': 61.06, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.082, 'oncotree_code': 'IDC', 'overall_survival_months': 82.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5110, 'age_at_diagnosis': 59.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 1.05, 'oncotree_code': 'ILC', 'overall_survival_months': 21.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5113, 'age_at_diagnosis': 43.8, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 175.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5114, 'age_at_diagnosis': 57.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 15.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5115, 'age_at_diagnosis': 40.57, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 77.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5116, 'age_at_diagnosis': 74.71, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 71.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5117, 'age_at_diagnosis': 51.09, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 209.2666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5118, 'age_at_diagnosis': 72.14, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 211.7333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5119, 'age_at_diagnosis': 75.33, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 59.76666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5120, 'age_at_diagnosis': 47.24, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 27.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5121, 'age_at_diagnosis': 72.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'ILC', 'overall_survival_months': 114.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5122, 'age_at_diagnosis': 77.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'MDLC', 'overall_survival_months': 125.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5123, 'age_at_diagnosis': 69.72, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 90.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5124, 'age_at_diagnosis': 83.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'IDC', 'overall_survival_months': 124.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5126, 'age_at_diagnosis': 63.48, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.02, 'oncotree_code': 'IDC', 'overall_survival_months': 27.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5127, 'age_at_diagnosis': 74.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'UNDEF', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 191.4666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5130, 'age_at_diagnosis': 58.61, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 255.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5134, 'age_at_diagnosis': 46.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'IDC', 'overall_survival_months': 196.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5135, 'age_at_diagnosis': 38.59, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 37.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5138, 'age_at_diagnosis': 44.59, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 37.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5139, 'age_at_diagnosis': 69.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.058, 'oncotree_code': 'IDC', 'overall_survival_months': 89.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5143, 'age_at_diagnosis': 78.8, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 127.9333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5144, 'age_at_diagnosis': 57.14, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 213.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5145, 'age_at_diagnosis': 61.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 159.2333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5147, 'age_at_diagnosis': 54.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'ILC', 'overall_survival_months': 20.26666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5148, 'age_at_diagnosis': 76.72, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 245.2333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5150, 'age_at_diagnosis': 69.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.002, 'oncotree_code': 'ILC', 'overall_survival_months': 110.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5152, 'age_at_diagnosis': 76.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 16.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 115.9333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5154, 'age_at_diagnosis': 31.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.002, 'oncotree_code': 'IDC', 'overall_survival_months': 170.8333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5155, 'age_at_diagnosis': 51.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.06, 'oncotree_code': 'IDC', 'overall_survival_months': 259.9333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5157, 'age_at_diagnosis': 70.68, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.024, 'oncotree_code': 'IDC', 'overall_survival_months': 18.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5160, 'age_at_diagnosis': 68.52, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 87.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5161, 'age_at_diagnosis': 44.41, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 175.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5162, 'age_at_diagnosis': 53.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 164.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5163, 'age_at_diagnosis': 69.04, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 212.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5164, 'age_at_diagnosis': 48.76, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 80.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5166, 'age_at_diagnosis': 69.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 11, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'IDC', 'overall_survival_months': 80.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5167, 'age_at_diagnosis': 60.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 1.06, 'oncotree_code': 'IDC', 'overall_survival_months': 208.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5169, 'age_at_diagnosis': 62.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 15.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 51.96666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5171, 'age_at_diagnosis': 46.79, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.022, 'oncotree_code': 'IDC', 'overall_survival_months': 185.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5172, 'age_at_diagnosis': 49.57, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 11.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'IDC', 'overall_survival_months': 184.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5173, 'age_at_diagnosis': 69.05, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 22.13333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5174, 'age_at_diagnosis': 54.69, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 1.03, 'oncotree_code': 'IDC', 'overall_survival_months': 151.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5175, 'age_at_diagnosis': 50.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.036, 'oncotree_code': 'IDC', 'overall_survival_months': 194.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5176, 'age_at_diagnosis': 53.96, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 19.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': nan, 'overall_survival_months': 112.6333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5177, 'age_at_diagnosis': 68.53, 'type_of_breast_surgery': nan, 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.0, 'oncotree_code': 'IDC', 'overall_survival_months': 65.23333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5178, 'age_at_diagnosis': 65.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'ILC', 'overall_survival_months': 184.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5179, 'age_at_diagnosis': 68.6, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 246.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5182, 'age_at_diagnosis': 78.04, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 134.2666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5183, 'age_at_diagnosis': 74.34, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 118.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5184, 'age_at_diagnosis': 79.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'ILC', 'overall_survival_months': 89.33333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5185, 'age_at_diagnosis': 61.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 77.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5186, 'age_at_diagnosis': 42.84, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 1.02, 'oncotree_code': 'IDC', 'overall_survival_months': 203.2666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5188, 'age_at_diagnosis': 65.44, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 19.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5189, 'age_at_diagnosis': 69.24, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 9, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 111.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5190, 'age_at_diagnosis': 53.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': nan, 'overall_survival_months': 242.5666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5191, 'age_at_diagnosis': 54.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'ILC', 'overall_survival_months': 142.1666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5193, 'age_at_diagnosis': 88.8, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 54.26666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5195, 'age_at_diagnosis': 72.16, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 196.8666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5196, 'age_at_diagnosis': 52.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 94.03333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5197, 'age_at_diagnosis': 62.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 223.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5199, 'age_at_diagnosis': 65.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 204.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5200, 'age_at_diagnosis': 70.23, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 52.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5201, 'age_at_diagnosis': 73.17, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 96.96666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5204, 'age_at_diagnosis': 76.91, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.048, 'oncotree_code': 'IDC', 'overall_survival_months': 191.9333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5205, 'age_at_diagnosis': 50.24, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 185.3, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5206, 'age_at_diagnosis': 67.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 205.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5208, 'age_at_diagnosis': 52.43, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 151.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5209, 'age_at_diagnosis': 79.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.12, 'oncotree_code': 'IDC', 'overall_survival_months': 175.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5211, 'age_at_diagnosis': 68.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 247.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5212, 'age_at_diagnosis': 80.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 179.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5213, 'age_at_diagnosis': 74.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 12, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'IDC', 'overall_survival_months': 43.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5214, 'age_at_diagnosis': 66.57, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 107.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5215, 'age_at_diagnosis': 74.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.056, 'oncotree_code': 'IDC', 'overall_survival_months': 118.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5218, 'age_at_diagnosis': 42.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'IDC', 'overall_survival_months': 254.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5221, 'age_at_diagnosis': 63.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 131.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5222, 'age_at_diagnosis': 76.2, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 111.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5223, 'age_at_diagnosis': 42.05, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 144.6666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5224, 'age_at_diagnosis': 90.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 99.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5225, 'age_at_diagnosis': 68.01, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 43.26666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5226, 'age_at_diagnosis': 75.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 200.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5227, 'age_at_diagnosis': 74.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 187.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5228, 'age_at_diagnosis': 72.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 180.7333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5229, 'age_at_diagnosis': 39.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 33.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5230, 'age_at_diagnosis': 48.17, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IMMC', 'overall_survival_months': 176.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5231, 'age_at_diagnosis': 61.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 16.56666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5232, 'age_at_diagnosis': 74.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'IDC', 'overall_survival_months': 211.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5233, 'age_at_diagnosis': 79.59, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 209.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5235, 'age_at_diagnosis': 59.04, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 3.012, 'oncotree_code': 'IDC', 'overall_survival_months': 204.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5236, 'age_at_diagnosis': 63.02, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.13, 'oncotree_code': 'IDC', 'overall_survival_months': 166.6666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5238, 'age_at_diagnosis': 46.03, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 44.13333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5239, 'age_at_diagnosis': 69.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 192.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5240, 'age_at_diagnosis': 56.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'MDLC', 'overall_survival_months': 103.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5243, 'age_at_diagnosis': 62.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.11, 'oncotree_code': 'IDC', 'overall_survival_months': 38.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5244, 'age_at_diagnosis': 69.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 216.8666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5251, 'age_at_diagnosis': 76.77, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 112.4666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5253, 'age_at_diagnosis': 69.59, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 102.0666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5256, 'age_at_diagnosis': 70.31, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 108.0666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5258, 'age_at_diagnosis': 72.77, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 101.0666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5259, 'age_at_diagnosis': 41.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 10.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 46.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5260, 'age_at_diagnosis': 72.23, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 202.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5261, 'age_at_diagnosis': 66.12, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 116.4666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5264, 'age_at_diagnosis': 46.4, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 199.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5266, 'age_at_diagnosis': 76.83, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 83.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5267, 'age_at_diagnosis': 52.77, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 71.06666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5268, 'age_at_diagnosis': 47.98, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 186.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5270, 'age_at_diagnosis': 67.1, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'MDLC', 'overall_survival_months': 187.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5271, 'age_at_diagnosis': 58.25, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'IDC', 'overall_survival_months': 167.5, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5272, 'age_at_diagnosis': 40.71, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 201.9333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5273, 'age_at_diagnosis': 60.33, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 60.86666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5275, 'age_at_diagnosis': 72.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 80.0, 'nottingham_prognostic_index': 3.0, 'oncotree_code': 'IDC', 'overall_survival_months': 75.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5277, 'age_at_diagnosis': 35.78, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 221.0666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5278, 'age_at_diagnosis': 47.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 1.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 99.96666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5279, 'age_at_diagnosis': 66.55, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 68.76666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5280, 'age_at_diagnosis': 45.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.004, 'oncotree_code': 'MDLC', 'overall_survival_months': 77.86666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5281, 'age_at_diagnosis': 55.72, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 79.3, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5284, 'age_at_diagnosis': 68.18, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'MDLC', 'overall_survival_months': 65.33333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5287, 'age_at_diagnosis': 69.46, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 124.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5288, 'age_at_diagnosis': 70.1, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 22.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 128.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5290, 'age_at_diagnosis': 69.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IDC', 'overall_survival_months': 36.93333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5291, 'age_at_diagnosis': 67.25, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 153.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5292, 'age_at_diagnosis': 82.06, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.01, 'oncotree_code': 'IDC', 'overall_survival_months': 48.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5293, 'age_at_diagnosis': 70.86, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 208.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5294, 'age_at_diagnosis': 31.71, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 14, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.198, 'oncotree_code': 'IDC', 'overall_survival_months': 195.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5295, 'age_at_diagnosis': 60.51, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 75.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5296, 'age_at_diagnosis': 78.93, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'IDC', 'overall_survival_months': 13.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5298, 'age_at_diagnosis': 49.63, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.046, 'oncotree_code': 'ILC', 'overall_survival_months': 84.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5299, 'age_at_diagnosis': 53.35, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'ILC', 'overall_survival_months': 16.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5300, 'age_at_diagnosis': 55.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'IDC', 'overall_survival_months': 190.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5305, 'age_at_diagnosis': 61.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 149.4333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5306, 'age_at_diagnosis': 58.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 159.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5308, 'age_at_diagnosis': 67.62, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 104.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5310, 'age_at_diagnosis': 71.4, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 153.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5311, 'age_at_diagnosis': 73.01, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.054, 'oncotree_code': 'IDC', 'overall_survival_months': 57.66666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5312, 'age_at_diagnosis': 50.6, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.12, 'oncotree_code': 'IDC', 'overall_survival_months': 37.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5313, 'age_at_diagnosis': 79.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 14, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'ILC', 'overall_survival_months': 46.53333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5315, 'age_at_diagnosis': 52.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 16, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.16, 'oncotree_code': 'IDC', 'overall_survival_months': 43.03333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5317, 'age_at_diagnosis': 69.7, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 53.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5318, 'age_at_diagnosis': 60.96, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 14.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5322, 'age_at_diagnosis': 66.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'MDLC', 'overall_survival_months': 102.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5323, 'age_at_diagnosis': 31.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 226.0666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5324, 'age_at_diagnosis': 64.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 14.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'MDLC', 'overall_survival_months': 190.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5326, 'age_at_diagnosis': 79.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 2.096, 'oncotree_code': 'ILC', 'overall_survival_months': 96.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5327, 'age_at_diagnosis': 66.94, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'ILC', 'overall_survival_months': 163.5333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5328, 'age_at_diagnosis': 74.57, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 14.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5329, 'age_at_diagnosis': 64.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 13, 'mutation_count': 14.0, 'nottingham_prognostic_index': 6.13, 'oncotree_code': 'ILC', 'overall_survival_months': 45.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5330, 'age_at_diagnosis': 70.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'ILC', 'overall_survival_months': 114.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5331, 'age_at_diagnosis': 54.69, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'IDC', 'overall_survival_months': 124.1333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5332, 'age_at_diagnosis': 68.93, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 98.83333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5334, 'age_at_diagnosis': 78.44, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 85.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5335, 'age_at_diagnosis': 41.81, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 25.23333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5338, 'age_at_diagnosis': 61.24, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 51.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5339, 'age_at_diagnosis': 71.78, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'NC', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 195.8666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5341, 'age_at_diagnosis': 56.37, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 250.8333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5345, 'age_at_diagnosis': 76.87, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 216.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5346, 'age_at_diagnosis': 52.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.16, 'oncotree_code': 'IDC', 'overall_survival_months': 194.3, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5347, 'age_at_diagnosis': 56.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 211.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5348, 'age_at_diagnosis': 41.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 169.6666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5350, 'age_at_diagnosis': 66.7, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 53.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5351, 'age_at_diagnosis': 47.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.004, 'oncotree_code': 'IDC', 'overall_survival_months': 202.1, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5358, 'age_at_diagnosis': 72.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.114, 'oncotree_code': 'MDLC', 'overall_survival_months': 28.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5360, 'age_at_diagnosis': 66.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.14, 'oncotree_code': 'MDLC', 'overall_survival_months': 161.1333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5361, 'age_at_diagnosis': 76.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 15.36666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5364, 'age_at_diagnosis': 56.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 125.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5365, 'age_at_diagnosis': 79.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 23.03333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5366, 'age_at_diagnosis': 75.56, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'ILC', 'overall_survival_months': 243.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5368, 'age_at_diagnosis': 77.15, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': nan, 'overall_survival_months': 100.1333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5369, 'age_at_diagnosis': 66.18, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 39.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5370, 'age_at_diagnosis': 62.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 119.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5373, 'age_at_diagnosis': 67.13, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 2.533333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5377, 'age_at_diagnosis': 35.14, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.09, 'oncotree_code': 'IDC', 'overall_survival_months': 102.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5378, 'age_at_diagnosis': 57.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.09, 'oncotree_code': 'IDC', 'overall_survival_months': 12.26666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5381, 'age_at_diagnosis': 44.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.1, 'oncotree_code': 'IDC', 'overall_survival_months': 201.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5382, 'age_at_diagnosis': 69.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 116.2333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5383, 'age_at_diagnosis': 83.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.15, 'oncotree_code': 'IDC', 'overall_survival_months': 113.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5384, 'age_at_diagnosis': 61.05, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': nan, 'overall_survival_months': 71.16666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5386, 'age_at_diagnosis': 65.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 192.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5388, 'age_at_diagnosis': 69.8, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 146.9333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5389, 'age_at_diagnosis': 64.76, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.062, 'oncotree_code': 'IDC', 'overall_survival_months': 124.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5390, 'age_at_diagnosis': 37.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 12, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.026, 'oncotree_code': 'ILC', 'overall_survival_months': 30.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5392, 'age_at_diagnosis': 57.34, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'ILC', 'overall_survival_months': 237.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5393, 'age_at_diagnosis': 82.72, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'MDLC', 'overall_survival_months': 154.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5395, 'age_at_diagnosis': 71.51, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'IDC', 'overall_survival_months': 165.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5396, 'age_at_diagnosis': 61.84, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.028, 'oncotree_code': 'IDC', 'overall_survival_months': 165.6666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5397, 'age_at_diagnosis': 61.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 172.8666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5398, 'age_at_diagnosis': 71.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 213.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5399, 'age_at_diagnosis': 73.1, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.044, 'oncotree_code': 'IDC', 'overall_survival_months': 106.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5401, 'age_at_diagnosis': 75.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'MDLC', 'overall_survival_months': 70.16666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5402, 'age_at_diagnosis': 81.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 107.7666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5403, 'age_at_diagnosis': 85.94, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 10, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 95.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5404, 'age_at_diagnosis': 81.57, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 74.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5405, 'age_at_diagnosis': 64.43, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': nan, 'overall_survival_months': 117.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5406, 'age_at_diagnosis': 80.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 97.43333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5407, 'age_at_diagnosis': 36.03, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.002, 'oncotree_code': 'IDC', 'overall_survival_months': 205.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5408, 'age_at_diagnosis': 65.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 101.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5409, 'age_at_diagnosis': 51.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.044, 'oncotree_code': 'IDC', 'overall_survival_months': 198.1333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5410, 'age_at_diagnosis': 66.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 202.7666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5411, 'age_at_diagnosis': 43.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 26.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5412, 'age_at_diagnosis': 51.87, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'IDC', 'overall_survival_months': 220.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5414, 'age_at_diagnosis': 61.14, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 140.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5417, 'age_at_diagnosis': 45.8, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 10.0, 'nottingham_prognostic_index': 6.12, 'oncotree_code': 'IDC', 'overall_survival_months': 107.0666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5418, 'age_at_diagnosis': 64.15, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 207.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5420, 'age_at_diagnosis': 71.49, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': nan, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 193.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5421, 'age_at_diagnosis': 68.0, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 194.5666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5422, 'age_at_diagnosis': 47.14, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.064, 'oncotree_code': 'IDC', 'overall_survival_months': 46.06666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5424, 'age_at_diagnosis': 66.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'MDLC', 'overall_survival_months': 83.53333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5425, 'age_at_diagnosis': 67.59, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 49.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5426, 'age_at_diagnosis': 53.69, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 11, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'IDC', 'overall_survival_months': 34.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5427, 'age_at_diagnosis': 83.68, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 155.7333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5428, 'age_at_diagnosis': 55.36, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 150.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5429, 'age_at_diagnosis': 86.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 30.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5431, 'age_at_diagnosis': 49.91, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 15.86666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5432, 'age_at_diagnosis': 61.0, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 98.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5433, 'age_at_diagnosis': 69.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 176.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5434, 'age_at_diagnosis': 71.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 18.0, 'nottingham_prognostic_index': 5.11, 'oncotree_code': 'IDC', 'overall_survival_months': 45.16666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5435, 'age_at_diagnosis': 77.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 1.05, 'oncotree_code': 'IDC', 'overall_survival_months': 104.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5440, 'age_at_diagnosis': 49.05, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 196.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5441, 'age_at_diagnosis': 90.08, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 9.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5442, 'age_at_diagnosis': 44.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 205.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5444, 'age_at_diagnosis': 49.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 240.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5446, 'age_at_diagnosis': 51.25, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 162.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5447, 'age_at_diagnosis': 68.1, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 148.8666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5450, 'age_at_diagnosis': 38.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.024, 'oncotree_code': 'IDC', 'overall_survival_months': 190.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5451, 'age_at_diagnosis': 43.44, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 189.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5452, 'age_at_diagnosis': 66.2, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 16.16666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5453, 'age_at_diagnosis': 36.99, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 57.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5454, 'age_at_diagnosis': 55.57, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'IDC', 'overall_survival_months': 50.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5455, 'age_at_diagnosis': 73.24, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.02, 'oncotree_code': 'MDLC', 'overall_survival_months': 61.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5457, 'age_at_diagnosis': 52.57, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 164.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5458, 'age_at_diagnosis': 54.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 183.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5459, 'age_at_diagnosis': 64.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 90.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5463, 'age_at_diagnosis': 71.91, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 16, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.096, 'oncotree_code': 'ILC', 'overall_survival_months': 58.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5464, 'age_at_diagnosis': 65.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.036, 'oncotree_code': 'IDC', 'overall_survival_months': 116.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5465, 'age_at_diagnosis': 69.83, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 18.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5468, 'age_at_diagnosis': 48.1, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 99.36666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5470, 'age_at_diagnosis': 48.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.0, 'oncotree_code': 'MDLC', 'overall_survival_months': 42.06666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5471, 'age_at_diagnosis': 67.54, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 185.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5472, 'age_at_diagnosis': 74.78, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 19.56666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5473, 'age_at_diagnosis': 72.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 125.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5474, 'age_at_diagnosis': 46.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 226.7, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5475, 'age_at_diagnosis': 73.55, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 2.533333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5477, 'age_at_diagnosis': 59.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.07, 'oncotree_code': 'BREAST', 'overall_survival_months': 110.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5478, 'age_at_diagnosis': 72.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 21, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 34.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5481, 'age_at_diagnosis': 57.62, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'UNDEF', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 46.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5482, 'age_at_diagnosis': 40.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'IDC', 'overall_survival_months': 17.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5483, 'age_at_diagnosis': 44.5, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 13.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 42.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5484, 'age_at_diagnosis': 47.3, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'ILC', 'overall_survival_months': 238.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5485, 'age_at_diagnosis': 80.08, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 31.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5486, 'age_at_diagnosis': 75.65, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 123.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5489, 'age_at_diagnosis': 53.6, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 216.9666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5490, 'age_at_diagnosis': 65.31, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'IDC', 'overall_survival_months': 51.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5491, 'age_at_diagnosis': 72.25, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.13, 'oncotree_code': 'IDC', 'overall_survival_months': 65.83333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5492, 'age_at_diagnosis': 74.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.102, 'oncotree_code': 'ILC', 'overall_survival_months': 23.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5493, 'age_at_diagnosis': 69.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.102, 'oncotree_code': 'ILC', 'overall_survival_months': 57.23333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5495, 'age_at_diagnosis': 42.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 228.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5497, 'age_at_diagnosis': 69.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 237.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5498, 'age_at_diagnosis': 64.1, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 225.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5499, 'age_at_diagnosis': 65.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 123.7333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5502, 'age_at_diagnosis': 51.62, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.056, 'oncotree_code': 'IDC', 'overall_survival_months': 189.7333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5505, 'age_at_diagnosis': 74.26, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 164.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5510, 'age_at_diagnosis': 75.73, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'MDLC', 'overall_survival_months': 103.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5511, 'age_at_diagnosis': 54.18, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 158.9666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5513, 'age_at_diagnosis': 86.55, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.058, 'oncotree_code': 'IDC', 'overall_survival_months': 36.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5514, 'age_at_diagnosis': 63.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 182.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5518, 'age_at_diagnosis': 72.39, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 30.86666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5519, 'age_at_diagnosis': 72.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.09, 'oncotree_code': 'IDC', 'overall_survival_months': 169.2333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5520, 'age_at_diagnosis': 38.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 16.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5521, 'age_at_diagnosis': 69.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.09, 'oncotree_code': 'IDC', 'overall_survival_months': 124.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5525, 'age_at_diagnosis': 63.2, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'IMMC', 'overall_survival_months': 2.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5526, 'age_at_diagnosis': 45.42, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 151.0666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5527, 'age_at_diagnosis': 53.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 8, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.022, 'oncotree_code': 'IDC', 'overall_survival_months': 180.5666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5529, 'age_at_diagnosis': 40.21, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 14.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5530, 'age_at_diagnosis': 50.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 185.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5531, 'age_at_diagnosis': 66.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 183.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5532, 'age_at_diagnosis': 69.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 79.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5533, 'age_at_diagnosis': 71.64, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 158.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5534, 'age_at_diagnosis': 80.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 10, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 79.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5535, 'age_at_diagnosis': 49.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.044, 'oncotree_code': 'IDC', 'overall_survival_months': 120.1333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5540, 'age_at_diagnosis': 76.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 48.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5541, 'age_at_diagnosis': 60.13, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 200.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5543, 'age_at_diagnosis': 79.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 34.43333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5547, 'age_at_diagnosis': 43.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 98.56666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5548, 'age_at_diagnosis': 62.43, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 25.33333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5549, 'age_at_diagnosis': 54.83, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 88.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5550, 'age_at_diagnosis': 84.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'IDC', 'overall_survival_months': 171.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5551, 'age_at_diagnosis': 67.24, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 182.2333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5552, 'age_at_diagnosis': 69.77, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.08, 'oncotree_code': 'IDC', 'overall_survival_months': 34.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5553, 'age_at_diagnosis': 70.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 154.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5554, 'age_at_diagnosis': 57.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.052, 'oncotree_code': 'ILC', 'overall_survival_months': 229.8333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5556, 'age_at_diagnosis': 53.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 225.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5558, 'age_at_diagnosis': 35.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.15, 'oncotree_code': 'IDC', 'overall_survival_months': 25.03333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5559, 'age_at_diagnosis': 42.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.096, 'oncotree_code': nan, 'overall_survival_months': 18.83333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5560, 'age_at_diagnosis': 44.05, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 186.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5562, 'age_at_diagnosis': 73.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 102.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5563, 'age_at_diagnosis': 76.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'ILC', 'overall_survival_months': 117.6666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5565, 'age_at_diagnosis': 64.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 194.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5566, 'age_at_diagnosis': 38.44, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 14, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.064, 'oncotree_code': 'IDC', 'overall_survival_months': 234.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5567, 'age_at_diagnosis': 74.95, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 178.5666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5571, 'age_at_diagnosis': 78.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 153.8666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5572, 'age_at_diagnosis': 47.88, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 178.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5575, 'age_at_diagnosis': 52.63, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 117.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5576, 'age_at_diagnosis': 67.79, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 194.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5577, 'age_at_diagnosis': 68.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.12, 'oncotree_code': 'ILC', 'overall_survival_months': 55.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5579, 'age_at_diagnosis': 68.82, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 90.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5580, 'age_at_diagnosis': 75.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 71.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5582, 'age_at_diagnosis': 46.43, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'IDC', 'overall_survival_months': 222.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5583, 'age_at_diagnosis': 50.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 111.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5584, 'age_at_diagnosis': 69.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 23.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 91.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5588, 'age_at_diagnosis': 66.55, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'MDLC', 'overall_survival_months': 81.13333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5589, 'age_at_diagnosis': 70.86, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 185.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5590, 'age_at_diagnosis': 64.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'IDC', 'overall_survival_months': 17.83333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5591, 'age_at_diagnosis': 46.28, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 14.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 155.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5592, 'age_at_diagnosis': 66.01, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'ILC', 'overall_survival_months': 26.33333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5593, 'age_at_diagnosis': 40.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 11.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'ILC', 'overall_survival_months': 92.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5596, 'age_at_diagnosis': 54.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 20, 'mutation_count': 11.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'ILC', 'overall_survival_months': 167.9333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5597, 'age_at_diagnosis': 75.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 32.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5599, 'age_at_diagnosis': 62.88, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 224.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5601, 'age_at_diagnosis': 61.73, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 214.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5602, 'age_at_diagnosis': 39.7, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 8, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.08, 'oncotree_code': 'IDC', 'overall_survival_months': 224.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5603, 'age_at_diagnosis': 70.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 171.6333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5604, 'age_at_diagnosis': 66.88, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 145.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5605, 'age_at_diagnosis': 40.37, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 123.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5613, 'age_at_diagnosis': 80.21, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 212.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5614, 'age_at_diagnosis': 62.87, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.034, 'oncotree_code': 'IDC', 'overall_survival_months': 116.4333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5616, 'age_at_diagnosis': 41.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 180.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5617, 'age_at_diagnosis': 81.63, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.064, 'oncotree_code': 'IDC', 'overall_survival_months': 128.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5620, 'age_at_diagnosis': 79.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.062, 'oncotree_code': 'IDC', 'overall_survival_months': 42.06666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5622, 'age_at_diagnosis': 62.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 182.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5623, 'age_at_diagnosis': 44.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 137.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5624, 'age_at_diagnosis': 55.43, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 17.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 136.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5626, 'age_at_diagnosis': 73.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 82.96666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5628, 'age_at_diagnosis': 65.06, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.0, 'oncotree_code': 'IDC', 'overall_survival_months': 42.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5629, 'age_at_diagnosis': 71.36, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 103.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5632, 'age_at_diagnosis': 78.55, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 38.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5633, 'age_at_diagnosis': 62.7, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 7, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'IDC', 'overall_survival_months': 35.03333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5634, 'age_at_diagnosis': 55.53, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 62.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5635, 'age_at_diagnosis': 57.2, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 21.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5636, 'age_at_diagnosis': 68.49, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.06, 'oncotree_code': 'IDC', 'overall_survival_months': 108.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5638, 'age_at_diagnosis': 65.14, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 195.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5640, 'age_at_diagnosis': 58.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.002, 'oncotree_code': 'IDC', 'overall_survival_months': 172.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5641, 'age_at_diagnosis': 78.64, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 181.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5642, 'age_at_diagnosis': 68.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.068, 'oncotree_code': 'IDC', 'overall_survival_months': 156.8, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5645, 'age_at_diagnosis': 71.31, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 22.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 5646, 'age_at_diagnosis': 58.4, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 167.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5647, 'age_at_diagnosis': 65.43, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 11, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 30.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5651, 'age_at_diagnosis': 51.98, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'MDLC', 'overall_survival_months': 21.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5652, 'age_at_diagnosis': 68.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 104.6666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 5653, 'age_at_diagnosis': 60.72, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 194.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5654, 'age_at_diagnosis': 82.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.11, 'oncotree_code': 'IDC', 'overall_survival_months': 173.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 5655, 'age_at_diagnosis': 67.57, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 3, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 191.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 5656, 'age_at_diagnosis': 74.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 3, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 126.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6001, 'age_at_diagnosis': 68.7, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'MDLC', 'overall_survival_months': 135.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6006, 'age_at_diagnosis': 86.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 2.032, 'oncotree_code': 'ILC', 'overall_survival_months': 63.56666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6007, 'age_at_diagnosis': 70.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 20.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'ILC', 'overall_survival_months': 70.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6008, 'age_at_diagnosis': 80.33, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'ILC', 'overall_survival_months': 69.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6010, 'age_at_diagnosis': 70.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 218.2333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6011, 'age_at_diagnosis': 59.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 1.05, 'oncotree_code': 'IDC', 'overall_survival_months': 211.1333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6012, 'age_at_diagnosis': 67.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.066, 'oncotree_code': 'ILC', 'overall_survival_months': 144.4333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6014, 'age_at_diagnosis': 44.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.114, 'oncotree_code': 'ILC', 'overall_survival_months': 191.9333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6016, 'age_at_diagnosis': 87.32, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'IDC', 'overall_survival_months': 143.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6017, 'age_at_diagnosis': 72.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.06, 'oncotree_code': 'IDC', 'overall_survival_months': 70.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6018, 'age_at_diagnosis': 65.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 143.1666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6019, 'age_at_diagnosis': 67.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.14, 'oncotree_code': 'IDC', 'overall_survival_months': 13.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6021, 'age_at_diagnosis': 51.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.0, 'oncotree_code': 'ILC', 'overall_survival_months': 301.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6022, 'age_at_diagnosis': 90.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 52.06666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6023, 'age_at_diagnosis': 60.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.068, 'oncotree_code': 'ILC', 'overall_survival_months': 232.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6024, 'age_at_diagnosis': 65.63, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 252.2666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6026, 'age_at_diagnosis': 87.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 49.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6029, 'age_at_diagnosis': 63.35, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 13.0, 'nottingham_prognostic_index': 6.02, 'oncotree_code': 'BREAST', 'overall_survival_months': 278.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6030, 'age_at_diagnosis': 66.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'IDC', 'overall_survival_months': 145.3666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6036, 'age_at_diagnosis': 44.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 287.9333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6039, 'age_at_diagnosis': 65.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 73.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6042, 'age_at_diagnosis': 70.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 263.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6044, 'age_at_diagnosis': 70.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 219.1, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6047, 'age_at_diagnosis': 72.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 12, 'mutation_count': 14.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'BREAST', 'overall_survival_months': 37.86666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6048, 'age_at_diagnosis': 58.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 168.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6049, 'age_at_diagnosis': 62.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 20.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'IDC', 'overall_survival_months': 264.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6050, 'age_at_diagnosis': 51.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 192.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6051, 'age_at_diagnosis': 65.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.072, 'oncotree_code': 'IDC', 'overall_survival_months': 186.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6052, 'age_at_diagnosis': 36.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 255.3666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6053, 'age_at_diagnosis': 69.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'IDC', 'overall_survival_months': 250.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6055, 'age_at_diagnosis': 33.08, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 12.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 200.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6058, 'age_at_diagnosis': 41.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 22.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6059, 'age_at_diagnosis': 50.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.096, 'oncotree_code': 'IDC', 'overall_survival_months': 278.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6060, 'age_at_diagnosis': 53.79, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 38.03333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6062, 'age_at_diagnosis': 31.6, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 282.3666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6063, 'age_at_diagnosis': 58.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 16, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.24, 'oncotree_code': 'IDC', 'overall_survival_months': 15.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6065, 'age_at_diagnosis': 76.69, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.096, 'oncotree_code': 'IDC', 'overall_survival_months': 188.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6068, 'age_at_diagnosis': 43.75, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.0, 'oncotree_code': 'IDC', 'overall_survival_months': 182.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6069, 'age_at_diagnosis': 75.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 258.1333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6071, 'age_at_diagnosis': 72.81, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 7, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.068, 'oncotree_code': 'IDC', 'overall_survival_months': 57.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6075, 'age_at_diagnosis': 84.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 182.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6077, 'age_at_diagnosis': 70.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'NC', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 170.2666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6079, 'age_at_diagnosis': 68.91, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.0, 'oncotree_code': 'IDC', 'overall_survival_months': 239.1666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6080, 'age_at_diagnosis': 79.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'IDC', 'overall_survival_months': 54.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6082, 'age_at_diagnosis': 46.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 8, 'mutation_count': 15.0, 'nottingham_prognostic_index': 5.14, 'oncotree_code': 'IDC', 'overall_survival_months': 102.5, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6083, 'age_at_diagnosis': 73.03, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.042, 'oncotree_code': 'IDC', 'overall_survival_months': 164.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6085, 'age_at_diagnosis': 58.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 12.0, 'nottingham_prognostic_index': 5.052, 'oncotree_code': 'IDC', 'overall_survival_months': 23.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6092, 'age_at_diagnosis': 80.59, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.042, 'oncotree_code': 'MDLC', 'overall_survival_months': 2.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6097, 'age_at_diagnosis': 68.59, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.016, 'oncotree_code': 'IDC', 'overall_survival_months': 159.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6098, 'age_at_diagnosis': 28.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.16, 'oncotree_code': 'IDC', 'overall_survival_months': 10.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6100, 'age_at_diagnosis': 53.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 10.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6101, 'age_at_diagnosis': 82.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.07, 'oncotree_code': 'IDC', 'overall_survival_months': 77.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6103, 'age_at_diagnosis': 66.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.0, 'oncotree_code': 'MDLC', 'overall_survival_months': 239.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6105, 'age_at_diagnosis': 78.93, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.026, 'oncotree_code': 'MDLC', 'overall_survival_months': 192.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6107, 'age_at_diagnosis': 71.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 4.0, 'oncotree_code': 'ILC', 'overall_survival_months': 123.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6108, 'age_at_diagnosis': 38.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 193.9666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6113, 'age_at_diagnosis': 39.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 124.5666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6114, 'age_at_diagnosis': 70.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 10, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 66.83333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6116, 'age_at_diagnosis': 66.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 193.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6118, 'age_at_diagnosis': 41.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 264.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6122, 'age_at_diagnosis': 54.74, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 260.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6124, 'age_at_diagnosis': 76.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 15, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.03, 'oncotree_code': 'IDC', 'overall_survival_months': 115.6333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6125, 'age_at_diagnosis': 63.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 153.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6131, 'age_at_diagnosis': 57.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.122, 'oncotree_code': 'IDC', 'overall_survival_months': 257.6666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6133, 'age_at_diagnosis': 74.6, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.078, 'oncotree_code': 'ILC', 'overall_survival_months': 61.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6135, 'age_at_diagnosis': 69.38, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 78.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6138, 'age_at_diagnosis': 85.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.074, 'oncotree_code': 'MDLC', 'overall_survival_months': 25.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6141, 'age_at_diagnosis': 79.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.0, 'oncotree_code': 'ILC', 'overall_survival_months': 78.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6143, 'age_at_diagnosis': 60.6, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.092, 'oncotree_code': 'IDC', 'overall_survival_months': 255.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6144, 'age_at_diagnosis': 64.55, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 254.9333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6145, 'age_at_diagnosis': 60.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.09, 'oncotree_code': 'MDLC', 'overall_survival_months': 34.33333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6146, 'age_at_diagnosis': 51.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.012, 'oncotree_code': 'IDC', 'overall_survival_months': 89.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6147, 'age_at_diagnosis': 76.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'ILC', 'overall_survival_months': 238.0666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6149, 'age_at_diagnosis': 70.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.052, 'oncotree_code': 'IDC', 'overall_survival_months': 74.93333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6150, 'age_at_diagnosis': 59.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.042, 'oncotree_code': 'IDC', 'overall_survival_months': 77.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6152, 'age_at_diagnosis': 60.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 13.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 228.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6154, 'age_at_diagnosis': 71.74, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 195.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6156, 'age_at_diagnosis': 49.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 58.93333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6157, 'age_at_diagnosis': 86.29, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 14, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 15.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6160, 'age_at_diagnosis': 46.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.0, 'oncotree_code': 'IDC', 'overall_survival_months': 247.3666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6163, 'age_at_diagnosis': 71.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'MDLC', 'overall_survival_months': 88.66666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6164, 'age_at_diagnosis': 77.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.026, 'oncotree_code': 'IDC', 'overall_survival_months': 205.9, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6167, 'age_at_diagnosis': 75.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'ILC', 'overall_survival_months': 122.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6168, 'age_at_diagnosis': 64.95, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 225.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6169, 'age_at_diagnosis': 39.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 84.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6171, 'age_at_diagnosis': 70.91, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'IDC', 'overall_survival_months': 220.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6178, 'age_at_diagnosis': 38.58, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 8, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.064, 'oncotree_code': 'IDC', 'overall_survival_months': 33.13333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6179, 'age_at_diagnosis': 59.08, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.066, 'oncotree_code': 'MDLC', 'overall_survival_months': 58.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6181, 'age_at_diagnosis': 83.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 54.93333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6182, 'age_at_diagnosis': 56.47, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 14.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 208.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6183, 'age_at_diagnosis': 66.24, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.036, 'oncotree_code': 'IDC', 'overall_survival_months': 79.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6184, 'age_at_diagnosis': 35.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 9, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 185.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6185, 'age_at_diagnosis': 75.44, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.032, 'oncotree_code': 'MDLC', 'overall_survival_months': 197.7333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6187, 'age_at_diagnosis': 70.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.158, 'oncotree_code': 'IDC', 'overall_survival_months': 37.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6188, 'age_at_diagnosis': 41.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 11, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.056, 'oncotree_code': 'IDC', 'overall_survival_months': 23.76666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6189, 'age_at_diagnosis': 56.25, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.084, 'oncotree_code': 'MDLC', 'overall_survival_months': 240.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6190, 'age_at_diagnosis': 79.24, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'IDC', 'overall_survival_months': 24.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6192, 'age_at_diagnosis': 78.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 42.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6194, 'age_at_diagnosis': 44.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 9, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 52.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6195, 'age_at_diagnosis': 66.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'ILC', 'overall_survival_months': 202.2333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6200, 'age_at_diagnosis': 65.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 30.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6201, 'age_at_diagnosis': 79.2, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'IDC', 'overall_survival_months': 222.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6204, 'age_at_diagnosis': 41.08, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 56.76666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6207, 'age_at_diagnosis': 80.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 118.3, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6208, 'age_at_diagnosis': 56.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 221.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6211, 'age_at_diagnosis': 82.1, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'IDC', 'overall_survival_months': 42.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6212, 'age_at_diagnosis': 61.81, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'BREAST', 'overall_survival_months': 224.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6214, 'age_at_diagnosis': 74.43, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 174.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6217, 'age_at_diagnosis': 47.51, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.0, 'oncotree_code': 'IMMC', 'overall_survival_months': 211.5333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6218, 'age_at_diagnosis': 49.67, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 147.7666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6223, 'age_at_diagnosis': 58.83, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 221.9333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6224, 'age_at_diagnosis': 66.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 31, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.02, 'oncotree_code': 'IDC', 'overall_survival_months': 35.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6225, 'age_at_diagnosis': 68.43, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 17.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 117.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6226, 'age_at_diagnosis': 73.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.074, 'oncotree_code': 'MDLC', 'overall_survival_months': 35.36666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6228, 'age_at_diagnosis': 37.33, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 200.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6229, 'age_at_diagnosis': 75.33, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'IDC', 'overall_survival_months': 0.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6231, 'age_at_diagnosis': 77.96, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 72.56666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6232, 'age_at_diagnosis': 71.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 11.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 85.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6233, 'age_at_diagnosis': 70.65, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 201.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6234, 'age_at_diagnosis': 66.35, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.0, 'oncotree_code': 'MDLC', 'overall_survival_months': 213.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6237, 'age_at_diagnosis': 75.62, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 105.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6238, 'age_at_diagnosis': 84.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.058, 'oncotree_code': 'MDLC', 'overall_survival_months': 172.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6239, 'age_at_diagnosis': 52.84, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 200.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6242, 'age_at_diagnosis': 41.29, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 8, 'mutation_count': 15.0, 'nottingham_prognostic_index': 6.11, 'oncotree_code': 'IDC', 'overall_survival_months': 165.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6245, 'age_at_diagnosis': 47.01, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 177.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6246, 'age_at_diagnosis': 58.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 52.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6248, 'age_at_diagnosis': 51.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.11, 'oncotree_code': 'IDC', 'overall_survival_months': 182.8333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6251, 'age_at_diagnosis': 48.59, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 14.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6253, 'age_at_diagnosis': 62.9, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.022, 'oncotree_code': 'ILC', 'overall_survival_months': 194.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6254, 'age_at_diagnosis': 78.69, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.142, 'oncotree_code': 'IMMC', 'overall_survival_months': 60.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6256, 'age_at_diagnosis': 67.33, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.028, 'oncotree_code': 'IDC', 'overall_survival_months': 127.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6257, 'age_at_diagnosis': 49.38, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 91.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6263, 'age_at_diagnosis': 79.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 8, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.048, 'oncotree_code': 'IDC', 'overall_survival_months': 75.86666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6271, 'age_at_diagnosis': 64.4, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 157.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6272, 'age_at_diagnosis': 36.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.0, 'oncotree_code': 'IDC', 'overall_survival_months': 22.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6273, 'age_at_diagnosis': 43.08, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Tubular/ cribriform', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 189.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6280, 'age_at_diagnosis': 53.68, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.088, 'oncotree_code': 'IDC', 'overall_survival_months': 27.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6281, 'age_at_diagnosis': 75.1, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 7, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.01, 'oncotree_code': 'IDC', 'overall_survival_months': 3.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6283, 'age_at_diagnosis': 73.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 10.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'ILC', 'overall_survival_months': 92.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6284, 'age_at_diagnosis': 67.81, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'BREAST', 'overall_survival_months': 88.33333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6286, 'age_at_diagnosis': 85.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 49.53333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6287, 'age_at_diagnosis': 58.08, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 35.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6288, 'age_at_diagnosis': 74.33, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 100.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6297, 'age_at_diagnosis': 52.55, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.06, 'oncotree_code': 'IDC', 'overall_survival_months': 170.8666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6300, 'age_at_diagnosis': 62.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 63.83333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6302, 'age_at_diagnosis': 67.78, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.054, 'oncotree_code': 'IDC', 'overall_survival_months': 125.8666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6305, 'age_at_diagnosis': 52.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 89.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6306, 'age_at_diagnosis': 78.22, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.058, 'oncotree_code': 'IDC', 'overall_survival_months': 64.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6308, 'age_at_diagnosis': 81.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 9, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.046, 'oncotree_code': 'IDC', 'overall_survival_months': 151.9333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6312, 'age_at_diagnosis': 85.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.078, 'oncotree_code': 'IDC', 'overall_survival_months': 162.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6314, 'age_at_diagnosis': 68.57, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'IMMC', 'overall_survival_months': 134.8333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6317, 'age_at_diagnosis': 86.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.106, 'oncotree_code': 'IDC', 'overall_survival_months': 29.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6318, 'age_at_diagnosis': 81.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 14.0, 'nottingham_prognostic_index': 4.07, 'oncotree_code': 'IDC', 'overall_survival_months': 109.2333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6319, 'age_at_diagnosis': 57.9, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 6, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.124, 'oncotree_code': 'ILC', 'overall_survival_months': 154.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6322, 'age_at_diagnosis': 80.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 9, 'mutation_count': 11.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'MDLC', 'overall_survival_months': 80.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6327, 'age_at_diagnosis': 76.56, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 10, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.12, 'oncotree_code': 'IMMC', 'overall_survival_months': 18.26666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6328, 'age_at_diagnosis': 75.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.06, 'oncotree_code': 'IDC', 'overall_survival_months': 126.6666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6329, 'age_at_diagnosis': 68.48, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 81.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6330, 'age_at_diagnosis': 36.81, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 140.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6334, 'age_at_diagnosis': 60.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 128.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 6336, 'age_at_diagnosis': 63.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 18, 'mutation_count': 2.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'IDC', 'overall_survival_months': 17.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6337, 'age_at_diagnosis': 58.25, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 14, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.11, 'oncotree_code': 'IDC', 'overall_survival_months': 110.8666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 6344, 'age_at_diagnosis': 82.0, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.12, 'oncotree_code': 'IDC', 'overall_survival_months': 152.9333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6346, 'age_at_diagnosis': 63.2, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Mixed Mucinous Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mucinous', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IMMC', 'overall_survival_months': 281.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 6358, 'age_at_diagnosis': 57.77, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'ILC', 'overall_survival_months': 37.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6359, 'age_at_diagnosis': 73.42, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 5, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IDC', 'overall_survival_months': 85.03333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 6363, 'age_at_diagnosis': 60.77, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 5, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'IDC', 'overall_survival_months': 16.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7000, 'age_at_diagnosis': 69.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.022, 'oncotree_code': 'BREAST', 'overall_survival_months': 97.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7001, 'age_at_diagnosis': 72.71, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 3.02, 'oncotree_code': 'IDC', 'overall_survival_months': 102.7, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7002, 'age_at_diagnosis': 74.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 57.93333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7003, 'age_at_diagnosis': 50.44, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 91.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7004, 'age_at_diagnosis': 74.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'ILC', 'overall_survival_months': 50.46666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7005, 'age_at_diagnosis': 70.84, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'IDC', 'overall_survival_months': 45.33333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7006, 'age_at_diagnosis': 58.8, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.038, 'oncotree_code': 'IDC', 'overall_survival_months': 109.9333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7007, 'age_at_diagnosis': 54.44, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.034, 'oncotree_code': 'IDC', 'overall_survival_months': 58.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7008, 'age_at_diagnosis': 69.94, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.048, 'oncotree_code': 'IDC', 'overall_survival_months': 50.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7009, 'age_at_diagnosis': 68.28, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.054, 'oncotree_code': 'IDC', 'overall_survival_months': 54.76666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7010, 'age_at_diagnosis': 70.25, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.046, 'oncotree_code': 'IDC', 'overall_survival_months': 74.03333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7011, 'age_at_diagnosis': 68.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'MDLC', 'overall_survival_months': 70.06666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7012, 'age_at_diagnosis': 60.96, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 19.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7013, 'age_at_diagnosis': 30.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.036, 'oncotree_code': 'IDC', 'overall_survival_months': 46.43333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7014, 'age_at_diagnosis': 67.57, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 16.0, 'nottingham_prognostic_index': 5.038, 'oncotree_code': 'MDLC', 'overall_survival_months': 68.7, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7015, 'age_at_diagnosis': 63.79, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 78.16666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7017, 'age_at_diagnosis': 36.63, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.054, 'oncotree_code': 'MDLC', 'overall_survival_months': 135.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7018, 'age_at_diagnosis': 72.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 86.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7019, 'age_at_diagnosis': 68.44, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.042, 'oncotree_code': 'IDC', 'overall_survival_months': 80.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7020, 'age_at_diagnosis': 44.47, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 10.0, 'nottingham_prognostic_index': 5.054, 'oncotree_code': 'IDC', 'overall_survival_months': 71.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7022, 'age_at_diagnosis': 70.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.068, 'oncotree_code': 'IDC', 'overall_survival_months': 85.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7023, 'age_at_diagnosis': 66.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 27.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7024, 'age_at_diagnosis': 54.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 70.26666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7025, 'age_at_diagnosis': 65.22, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.026, 'oncotree_code': 'IDC', 'overall_survival_months': 80.23333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7026, 'age_at_diagnosis': 35.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'IDC', 'overall_survival_months': 111.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7027, 'age_at_diagnosis': 60.56, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 12, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.03, 'oncotree_code': 'IDC', 'overall_survival_months': 36.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7028, 'age_at_diagnosis': 65.94, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'IDC', 'overall_survival_months': 89.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7029, 'age_at_diagnosis': 43.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.046, 'oncotree_code': 'IDC', 'overall_survival_months': 76.86666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7030, 'age_at_diagnosis': 74.21, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'BREAST', 'overall_survival_months': 31.33333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7031, 'age_at_diagnosis': 60.58, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 85.36666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7032, 'age_at_diagnosis': 79.36, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.046, 'oncotree_code': nan, 'overall_survival_months': 71.46666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7034, 'age_at_diagnosis': 78.73, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.086, 'oncotree_code': 'IDC', 'overall_survival_months': 75.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7035, 'age_at_diagnosis': 45.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 13, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 32.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7036, 'age_at_diagnosis': 54.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 120.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7037, 'age_at_diagnosis': 68.74, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.03, 'oncotree_code': 'IDC', 'overall_survival_months': 86.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7038, 'age_at_diagnosis': 57.62, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 16.0, 'nottingham_prognostic_index': 5.044, 'oncotree_code': 'IDC', 'overall_survival_months': 81.03333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7039, 'age_at_diagnosis': 78.19, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.124, 'oncotree_code': 'MDLC', 'overall_survival_months': 49.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7040, 'age_at_diagnosis': 81.32, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 71.83333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7041, 'age_at_diagnosis': 79.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 16.0, 'nottingham_prognostic_index': 1.05, 'oncotree_code': 'ILC', 'overall_survival_months': 101.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7042, 'age_at_diagnosis': 61.72, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 11.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'IDC', 'overall_survival_months': 88.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7043, 'age_at_diagnosis': 72.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 91.53333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7044, 'age_at_diagnosis': 67.24, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 86.83333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7045, 'age_at_diagnosis': 61.39, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 94.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7046, 'age_at_diagnosis': 76.02, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.046, 'oncotree_code': 'IDC', 'overall_survival_months': 146.4, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7048, 'age_at_diagnosis': 36.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.028, 'oncotree_code': 'IDC', 'overall_survival_months': 88.46666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7049, 'age_at_diagnosis': 48.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 102.0333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7050, 'age_at_diagnosis': 64.99, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.045, 'oncotree_code': 'IDC', 'overall_survival_months': 65.13333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7051, 'age_at_diagnosis': 63.44, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 85.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7052, 'age_at_diagnosis': 45.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.0358, 'oncotree_code': 'IDC', 'overall_survival_months': 106.1333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7053, 'age_at_diagnosis': 45.64, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.029, 'oncotree_code': 'IDC', 'overall_survival_months': 122.1333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7054, 'age_at_diagnosis': 73.74, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.0256, 'oncotree_code': 'ILC', 'overall_survival_months': 30.43333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7055, 'age_at_diagnosis': 54.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'IDC', 'overall_survival_months': 9.133333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7056, 'age_at_diagnosis': 71.82, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 20.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'IDC', 'overall_survival_months': 117.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7057, 'age_at_diagnosis': 72.81, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 43.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7058, 'age_at_diagnosis': 45.81, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.054, 'oncotree_code': 'IDC', 'overall_survival_months': 122.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7059, 'age_at_diagnosis': 50.55, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 23, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.048, 'oncotree_code': nan, 'overall_survival_months': 119.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7060, 'age_at_diagnosis': 69.25, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'ILC', 'overall_survival_months': 112.6666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7061, 'age_at_diagnosis': 61.6, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 96.76666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7062, 'age_at_diagnosis': 63.77, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 95.86666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7063, 'age_at_diagnosis': 76.77, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 86.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7065, 'age_at_diagnosis': 45.35, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.038, 'oncotree_code': 'IDC', 'overall_survival_months': 107.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7066, 'age_at_diagnosis': 64.24, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.037, 'oncotree_code': 'IDC', 'overall_survival_months': 89.76666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7067, 'age_at_diagnosis': 69.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.031, 'oncotree_code': 'IDC', 'overall_survival_months': 105.0, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7068, 'age_at_diagnosis': 58.95, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.052, 'oncotree_code': 'IDC', 'overall_survival_months': 98.46666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7069, 'age_at_diagnosis': 67.6, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 14.0, 'nottingham_prognostic_index': 4.043, 'oncotree_code': 'IDC', 'overall_survival_months': 114.6, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7070, 'age_at_diagnosis': 68.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.004, 'oncotree_code': 'IDC', 'overall_survival_months': 108.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7071, 'age_at_diagnosis': 27.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 22.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'ILC', 'overall_survival_months': 102.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7072, 'age_at_diagnosis': 71.24, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 14, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.13, 'oncotree_code': 'MDLC', 'overall_survival_months': 52.33333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7073, 'age_at_diagnosis': 54.69, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 13, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.04, 'oncotree_code': 'IDC', 'overall_survival_months': 137.9333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7074, 'age_at_diagnosis': 51.36, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.036, 'oncotree_code': 'IDC', 'overall_survival_months': 108.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7075, 'age_at_diagnosis': 64.4, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'MDLC', 'overall_survival_months': 111.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7076, 'age_at_diagnosis': 56.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.044, 'oncotree_code': 'IDC', 'overall_survival_months': 142.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7077, 'age_at_diagnosis': 37.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.034, 'oncotree_code': 'IDC', 'overall_survival_months': 101.2666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7078, 'age_at_diagnosis': 74.8, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 4.166666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7079, 'age_at_diagnosis': 70.3, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 91.06666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7080, 'age_at_diagnosis': 64.01, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.034, 'oncotree_code': 'IDC', 'overall_survival_months': 91.23333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7081, 'age_at_diagnosis': 69.12, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.056, 'oncotree_code': 'IDC', 'overall_survival_months': 140.2333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7082, 'age_at_diagnosis': 57.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 98.26666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7083, 'age_at_diagnosis': 50.42, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.052, 'oncotree_code': 'IDC', 'overall_survival_months': 105.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7084, 'age_at_diagnosis': 74.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.12, 'oncotree_code': nan, 'overall_survival_months': 116.5333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7085, 'age_at_diagnosis': 60.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 110.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7086, 'age_at_diagnosis': 70.52, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'MDLC', 'overall_survival_months': 123.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7087, 'age_at_diagnosis': 66.61, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 3, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.028, 'oncotree_code': 'IDC', 'overall_survival_months': 5.066666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7088, 'age_at_diagnosis': 72.05, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 123.5333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7089, 'age_at_diagnosis': 47.7, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 10.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 118.9, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7090, 'age_at_diagnosis': 48.52, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.034, 'oncotree_code': 'IDC', 'overall_survival_months': 109.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7091, 'age_at_diagnosis': 55.71, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 110.2666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7092, 'age_at_diagnosis': 55.67, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 2.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 122.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7093, 'age_at_diagnosis': 76.25, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.0338, 'oncotree_code': 'IDC', 'overall_survival_months': 125.8333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7094, 'age_at_diagnosis': 60.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.0488, 'oncotree_code': 'IDC', 'overall_survival_months': 113.3666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7095, 'age_at_diagnosis': 74.64, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.05, 'oncotree_code': 'IDC', 'overall_survival_months': 115.6333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7096, 'age_at_diagnosis': 48.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.025, 'oncotree_code': 'IDC', 'overall_survival_months': 124.0, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7097, 'age_at_diagnosis': 60.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 10.0, 'nottingham_prognostic_index': 2.0806, 'oncotree_code': 'IDC', 'overall_survival_months': 65.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7099, 'age_at_diagnosis': 80.31, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.076, 'oncotree_code': 'IDC', 'overall_survival_months': 163.1666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7100, 'age_at_diagnosis': 70.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.056, 'oncotree_code': 'IDC', 'overall_survival_months': 156.3333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7101, 'age_at_diagnosis': 49.16, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.031, 'oncotree_code': 'ILC', 'overall_survival_months': 124.2666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7102, 'age_at_diagnosis': 73.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'MDLC', 'overall_survival_months': 104.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7104, 'age_at_diagnosis': 59.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.038, 'oncotree_code': 'IDC', 'overall_survival_months': 122.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7106, 'age_at_diagnosis': 80.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 18, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.058, 'oncotree_code': 'IDC', 'overall_survival_months': 37.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7107, 'age_at_diagnosis': 67.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 11.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 56.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7109, 'age_at_diagnosis': 67.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 16, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.038, 'oncotree_code': 'IDC', 'overall_survival_months': 117.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7111, 'age_at_diagnosis': 52.12, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 5, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 30.16666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7112, 'age_at_diagnosis': 40.74, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 64.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7113, 'age_at_diagnosis': 66.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 2.02, 'oncotree_code': 'IDC', 'overall_survival_months': 136.7, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7114, 'age_at_diagnosis': 55.57, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.032, 'oncotree_code': 'IDC', 'overall_survival_months': 123.2666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7115, 'age_at_diagnosis': 80.56, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.14, 'oncotree_code': 'IDC', 'overall_survival_months': 141.7333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7116, 'age_at_diagnosis': 77.17, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 33.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7118, 'age_at_diagnosis': 70.15, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 140.5666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7119, 'age_at_diagnosis': 54.53, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.046, 'oncotree_code': 'IDC', 'overall_survival_months': 128.3666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7121, 'age_at_diagnosis': 49.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 4, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.076, 'oncotree_code': 'IDC', 'overall_survival_months': 88.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7122, 'age_at_diagnosis': 83.39, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 29.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7123, 'age_at_diagnosis': 56.97, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 2.072, 'oncotree_code': 'IDC', 'overall_survival_months': 137.6666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7124, 'age_at_diagnosis': 71.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 139.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7127, 'age_at_diagnosis': 52.43, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.038, 'oncotree_code': 'IDC', 'overall_survival_months': 135.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7128, 'age_at_diagnosis': 71.05, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.042, 'oncotree_code': nan, 'overall_survival_months': 60.26666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7130, 'age_at_diagnosis': 72.28, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.062, 'oncotree_code': 'IDC', 'overall_survival_months': 102.9666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7131, 'age_at_diagnosis': 58.04, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 14.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'IDC', 'overall_survival_months': 134.7333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7132, 'age_at_diagnosis': 69.06, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.038, 'oncotree_code': 'IDC', 'overall_survival_months': 131.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7133, 'age_at_diagnosis': 71.41, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'ILC', 'overall_survival_months': 23.83333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7135, 'age_at_diagnosis': 56.93, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 16, 'mutation_count': 7.0, 'nottingham_prognostic_index': 6.052, 'oncotree_code': 'IDC', 'overall_survival_months': 26.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7137, 'age_at_diagnosis': 64.24, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 2.042, 'oncotree_code': 'IDC', 'overall_survival_months': 179.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7138, 'age_at_diagnosis': 68.16, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.044, 'oncotree_code': 'IDC', 'overall_survival_months': 123.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7140, 'age_at_diagnosis': 58.27, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 5, 'mutation_count': 8.0, 'nottingham_prognostic_index': 6.12, 'oncotree_code': 'IDC', 'overall_survival_months': 90.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7141, 'age_at_diagnosis': 78.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.0236, 'oncotree_code': 'IDC', 'overall_survival_months': 138.5666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7142, 'age_at_diagnosis': 55.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.026, 'oncotree_code': 'IDC', 'overall_survival_months': 175.9, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7143, 'age_at_diagnosis': 61.38, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.068, 'oncotree_code': 'IDC', 'overall_survival_months': 186.3666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7144, 'age_at_diagnosis': 59.34, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.045, 'oncotree_code': 'IDC', 'overall_survival_months': 102.6333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7145, 'age_at_diagnosis': 44.42, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 138.3333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7147, 'age_at_diagnosis': 76.98, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'MDLC', 'overall_survival_months': 168.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7149, 'age_at_diagnosis': 66.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 14, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 44.63333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7150, 'age_at_diagnosis': 70.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 4.074, 'oncotree_code': 'IDC', 'overall_survival_months': 128.9666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7151, 'age_at_diagnosis': 59.06, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 144.4333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7152, 'age_at_diagnosis': 62.13, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.036, 'oncotree_code': 'IDC', 'overall_survival_months': 195.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7153, 'age_at_diagnosis': 74.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 12.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 142.8, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7154, 'age_at_diagnosis': 77.54, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 14.0, 'nottingham_prognostic_index': 4.0652, 'oncotree_code': 'IDC', 'overall_survival_months': 108.4666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7155, 'age_at_diagnosis': 41.14, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.0344, 'oncotree_code': 'IDC', 'overall_survival_months': 149.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7157, 'age_at_diagnosis': 56.86, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 2, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.038, 'oncotree_code': 'IDC', 'overall_survival_months': 219.6333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7158, 'age_at_diagnosis': 50.73, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER-', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 16, 'mutation_count': 6.0, 'nottingham_prognostic_index': 6.058, 'oncotree_code': 'IDC', 'overall_survival_months': 46.43333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7159, 'age_at_diagnosis': 60.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.068, 'oncotree_code': 'IDC', 'overall_survival_months': 21.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7160, 'age_at_diagnosis': 51.34, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 11.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 148.0666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7161, 'age_at_diagnosis': 47.67, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.092, 'oncotree_code': 'IDC', 'overall_survival_months': 121.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7162, 'age_at_diagnosis': 59.84, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 2.0276, 'oncotree_code': 'IDC', 'overall_survival_months': 140.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7163, 'age_at_diagnosis': 43.81, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 15, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 52.63333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7164, 'age_at_diagnosis': 49.13, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.0314, 'oncotree_code': 'IDC', 'overall_survival_months': 211.4, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7165, 'age_at_diagnosis': 28.78, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.364, 'oncotree_code': 'IDC', 'overall_survival_months': 147.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7167, 'age_at_diagnosis': 43.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.17, 'oncotree_code': 'IDC', 'overall_survival_months': 141.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7168, 'age_at_diagnosis': 60.33, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.05, 'oncotree_code': 'IDC', 'overall_survival_months': 150.5, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7170, 'age_at_diagnosis': 58.56, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 15.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'IDC', 'overall_survival_months': 155.4, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7171, 'age_at_diagnosis': 71.82, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.062, 'oncotree_code': 'IDC', 'overall_survival_months': 160.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7172, 'age_at_diagnosis': 62.7, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.0366, 'oncotree_code': 'IDC', 'overall_survival_months': 149.3, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7173, 'age_at_diagnosis': 67.4, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.0432, 'oncotree_code': 'ILC', 'overall_survival_months': 63.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7174, 'age_at_diagnosis': 60.63, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': nan, 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 140.7666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7176, 'age_at_diagnosis': 50.51, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.057, 'oncotree_code': 'IDC', 'overall_survival_months': 194.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7181, 'age_at_diagnosis': 63.09, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.042, 'oncotree_code': 'IDC', 'overall_survival_months': 157.5333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7182, 'age_at_diagnosis': 58.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 49.46666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7185, 'age_at_diagnosis': 70.76, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 8, 'mutation_count': 9.0, 'nottingham_prognostic_index': 5.0324, 'oncotree_code': 'IDC', 'overall_survival_months': 125.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7186, 'age_at_diagnosis': 48.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 6, 'mutation_count': 15.0, 'nottingham_prognostic_index': 5.066, 'oncotree_code': 'IDC', 'overall_survival_months': 4.866666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7187, 'age_at_diagnosis': 49.35, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 3.0046, 'oncotree_code': 'IDC', 'overall_survival_months': 146.8333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7189, 'age_at_diagnosis': 58.75, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.042, 'oncotree_code': 'IDC', 'overall_survival_months': 143.6, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7193, 'age_at_diagnosis': 76.65, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.0304, 'oncotree_code': 'IDC', 'overall_survival_months': 87.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7194, 'age_at_diagnosis': 63.71, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '2', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.043, 'oncotree_code': 'IDC', 'overall_survival_months': 46.66666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7195, 'age_at_diagnosis': 72.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'ILC', 'overall_survival_months': 80.43333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7196, 'age_at_diagnosis': 67.99, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 4, 'mutation_count': 5.0, 'nottingham_prognostic_index': 6.15, 'oncotree_code': 'IDC', 'overall_survival_months': 107.1, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7197, 'age_at_diagnosis': 70.58, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 187.8666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7198, 'age_at_diagnosis': 67.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.08, 'oncotree_code': 'IDC', 'overall_survival_months': 16.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7199, 'age_at_diagnosis': 81.14, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 76.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7200, 'age_at_diagnosis': 71.69, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 97.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7201, 'age_at_diagnosis': 62.07, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.032, 'oncotree_code': 'IDC', 'overall_survival_months': 163.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7205, 'age_at_diagnosis': 38.17, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 15.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 166.0333333, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7207, 'age_at_diagnosis': 43.28, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': nan, 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 2.06, 'oncotree_code': 'IDC', 'overall_survival_months': 55.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7208, 'age_at_diagnosis': 48.83, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 9, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.0622, 'oncotree_code': 'IDC', 'overall_survival_months': 45.93333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7212, 'age_at_diagnosis': 62.26, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.0286, 'oncotree_code': 'ILC', 'overall_survival_months': 52.5, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7215, 'age_at_diagnosis': 60.15, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Medullary', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.031, 'oncotree_code': 'IDC', 'overall_survival_months': 208.9666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7216, 'age_at_diagnosis': 79.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 1.0, 'nottingham_prognostic_index': 3.04, 'oncotree_code': 'ILC', 'overall_survival_months': 207.4666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7217, 'age_at_diagnosis': 62.61, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 1.02, 'oncotree_code': 'IDC', 'overall_survival_months': 90.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7218, 'age_at_diagnosis': 57.87, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 5.0, 'nottingham_prognostic_index': 3.0252, 'oncotree_code': 'ILC', 'overall_survival_months': 165.4333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7219, 'age_at_diagnosis': 60.07, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.025, 'oncotree_code': 'IDC', 'overall_survival_months': 165.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7220, 'age_at_diagnosis': 70.97, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.0502, 'oncotree_code': 'IDC', 'overall_survival_months': 183.2, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7225, 'age_at_diagnosis': 49.61, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 3, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.076, 'oncotree_code': 'IDC', 'overall_survival_months': 55.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7226, 'age_at_diagnosis': 67.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.0352, 'oncotree_code': 'IDC', 'overall_survival_months': 53.36666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7227, 'age_at_diagnosis': 72.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 2.0, 'nottingham_prognostic_index': 3.034, 'oncotree_code': 'IDC', 'overall_survival_months': 63.2, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7228, 'age_at_diagnosis': 58.92, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.07, 'oncotree_code': 'IDC', 'overall_survival_months': 239.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7229, 'age_at_diagnosis': 73.52, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Mixed Ductal and Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Mixed', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.058, 'oncotree_code': 'MDLC', 'overall_survival_months': 111.6, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7230, 'age_at_diagnosis': 51.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 3.03, 'oncotree_code': 'IDC', 'overall_survival_months': 182.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7231, 'age_at_diagnosis': 68.41, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 8.0, 'nottingham_prognostic_index': 1.076, 'oncotree_code': 'IDC', 'overall_survival_months': 199.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7232, 'age_at_diagnosis': 58.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.00424, 'oncotree_code': 'IDC', 'overall_survival_months': 177.6, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7233, 'age_at_diagnosis': 74.76, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 6.0, 'nottingham_prognostic_index': 3.0426, 'oncotree_code': 'IDC', 'overall_survival_months': 222.0333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7234, 'age_at_diagnosis': 63.43, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.016, 'oncotree_code': 'IDC', 'overall_survival_months': 222.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7235, 'age_at_diagnosis': 62.45, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Other', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 12.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'BREAST', 'overall_survival_months': 170.8, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7236, 'age_at_diagnosis': 51.46, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': nan, 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': nan, 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 5, 'mutation_count': 1.0, 'nottingham_prognostic_index': 5.04464, 'oncotree_code': nan, 'overall_survival_months': 201.4666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7237, 'age_at_diagnosis': 77.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'NC', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 8, 'mutation_count': 10.0, 'nottingham_prognostic_index': 5.036, 'oncotree_code': 'IDC', 'overall_survival_months': 23.93333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7238, 'age_at_diagnosis': 71.11, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 7.0, 'nottingham_prognostic_index': 4.054, 'oncotree_code': 'IDC', 'overall_survival_months': 23.26666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7241, 'age_at_diagnosis': 47.85, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '7', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 171.1, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7243, 'age_at_diagnosis': 78.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 5.0, 'nottingham_prognostic_index': 2.034, 'oncotree_code': 'IDC', 'overall_survival_months': 148.8, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7244, 'age_at_diagnosis': 54.81, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 10.0, 'nottingham_prognostic_index': 3.024, 'oncotree_code': 'IDC', 'overall_survival_months': 184.1666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7249, 'age_at_diagnosis': 75.13, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Low', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': nan, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 4.0, 'nottingham_prognostic_index': 1.042, 'oncotree_code': 'IDC', 'overall_survival_months': 58.66666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7250, 'age_at_diagnosis': 48.45, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 10.0, 'nottingham_prognostic_index': 4.0354, 'oncotree_code': 'IDC', 'overall_survival_months': 51.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7251, 'age_at_diagnosis': 54.66, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 5, 'mutation_count': 1.0, 'nottingham_prognostic_index': 6.03094, 'oncotree_code': 'IDC', 'overall_survival_months': 21.56666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7252, 'age_at_diagnosis': 74.8, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 5, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 35.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7253, 'age_at_diagnosis': 69.72, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 0, 'mutation_count': 3.0, 'nottingham_prognostic_index': 3.05, 'oncotree_code': 'IDC', 'overall_survival_months': 59.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7254, 'age_at_diagnosis': 62.46, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 8.0, 'nottingham_prognostic_index': 4.046, 'oncotree_code': 'IDC', 'overall_survival_months': 192.2, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7256, 'age_at_diagnosis': 50.92, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 17, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 34.7, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7258, 'age_at_diagnosis': 45.11, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 6, 'mutation_count': 12.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'IDC', 'overall_survival_months': 15.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7260, 'age_at_diagnosis': 52.41, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 7, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.0483, 'oncotree_code': 'IDC', 'overall_survival_months': 31.16666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7262, 'age_at_diagnosis': 83.8, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 10.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 104.0333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7263, 'age_at_diagnosis': 63.89, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 2, 'mutation_count': 6.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 164.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7264, 'age_at_diagnosis': 60.57, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 11, 'mutation_count': 3.0, 'nottingham_prognostic_index': 6.07, 'oncotree_code': 'IDC', 'overall_survival_months': 42.96666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7266, 'age_at_diagnosis': 59.82, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 3.08, 'oncotree_code': 'IDC', 'overall_survival_months': 68.16666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7267, 'age_at_diagnosis': 28.37, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 7.0, 'nottingham_prognostic_index': 5.041, 'oncotree_code': 'IDC', 'overall_survival_months': 195.3666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7268, 'age_at_diagnosis': 34.64, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.1, 'oncotree_code': 'IDC', 'overall_survival_months': 227.4666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7269, 'age_at_diagnosis': 36.6, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 2, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 21.16666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7270, 'age_at_diagnosis': 50.84, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Basal', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'IDC', 'overall_survival_months': 175.1666667, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7273, 'age_at_diagnosis': 47.47, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'ILC', 'overall_survival_months': 208.2, 'overall_survival': 1, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7275, 'age_at_diagnosis': 30.02, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Negative', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 3, 'mutation_count': 8.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 44.4, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7276, 'age_at_diagnosis': 61.27, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 1.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 4, 'mutation_count': 9.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 185.3333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7277, 'age_at_diagnosis': 56.78, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.06, 'oncotree_code': 'IDC', 'overall_survival_months': 187.0333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7278, 'age_at_diagnosis': 67.89, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 241.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7279, 'age_at_diagnosis': 86.14, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '9', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 3, 'mutation_count': 4.0, 'nottingham_prognostic_index': 4.1, 'oncotree_code': 'IDC', 'overall_survival_months': 21.3, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7280, 'age_at_diagnosis': 63.5, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '7', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 6, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.08, 'oncotree_code': 'IDC', 'overall_survival_months': 195.5333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7281, 'age_at_diagnosis': 51.22, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'Her2', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 3, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.032, 'oncotree_code': 'IDC', 'overall_survival_months': 49.53333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7283, 'age_at_diagnosis': 54.42, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 1, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'LOSS', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 33, 'mutation_count': 10.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'ILC', 'overall_survival_months': 28.86666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7284, 'age_at_diagnosis': 61.23, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.03, 'oncotree_code': 'IDC', 'overall_survival_months': 203.0, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7285, 'age_at_diagnosis': 53.14, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 3, 'mutation_count': 1.0, 'nottingham_prognostic_index': 4.04, 'oncotree_code': 'IDC', 'overall_survival_months': 109.0, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7286, 'age_at_diagnosis': 66.48, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 3, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 158.6333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7287, 'age_at_diagnosis': 63.09, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 10, 'mutation_count': 9.0, 'nottingham_prognostic_index': 6.06, 'oncotree_code': 'IDC', 'overall_survival_months': 96.96666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7288, 'age_at_diagnosis': 55.7, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '8', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 8, 'mutation_count': 2.0, 'nottingham_prognostic_index': 5.06, 'oncotree_code': 'IDC', 'overall_survival_months': 27.06666667, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7289, 'age_at_diagnosis': 51.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'Normal', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '4ER+', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 5, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.13, 'oncotree_code': 'IDC', 'overall_survival_months': 126.6666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7291, 'age_at_diagnosis': 53.87, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'claudin-low', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Negative', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 22, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.1, 'oncotree_code': 'IDC', 'overall_survival_months': 6.833333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 0}
{'patient_id': 7292, 'age_at_diagnosis': 52.9, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '6', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 78.46666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7293, 'age_at_diagnosis': 56.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '3', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 5.0, 'nottingham_prognostic_index': 5.09, 'oncotree_code': 'IDC', 'overall_survival_months': 199.2333333, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7294, 'age_at_diagnosis': 59.2, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 2.0, 'nottingham_prognostic_index': 4.03, 'oncotree_code': 'IDC', 'overall_survival_months': 82.73333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7295, 'age_at_diagnosis': 43.1, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Lobular Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumA', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Lobular', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '3', 'primary_tumor_laterality': 'Right', 'lymph_nodes_examined_positive': 1, 'mutation_count': 4.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'ILC', 'overall_survival_months': 196.8666667, 'overall_survival': 1, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7296, 'age_at_diagnosis': 42.88, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'GAIN', 'her2_status': 'Positive', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 0, 'inferred_menopausal_state': 'Pre', 'integrative_cluster': '5', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 6.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 44.73333333, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
{'patient_id': 7297, 'age_at_diagnosis': 62.9, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': 'Left', 'lymph_nodes_examined_positive': 45, 'mutation_count': 4.0, 'nottingham_prognostic_index': 6.05, 'oncotree_code': 'IDC', 'overall_survival_months': 175.9666667, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 1}
{'patient_id': 7298, 'age_at_diagnosis': 61.16, 'type_of_breast_surgery': 'MASTECTOMY', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'Moderate', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 2.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '1', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 12, 'mutation_count': 15.0, 'nottingham_prognostic_index': 5.05, 'oncotree_code': 'IDC', 'overall_survival_months': 86.23333333, 'overall_survival': 0, 'pr_status': 'Positive', 'radio_therapy': 0}
{'patient_id': 7299, 'age_at_diagnosis': 60.02, 'type_of_breast_surgery': 'BREAST CONSERVING', 'cancer_type': 'Breast Cancer', 'cancer_type_detailed': 'Breast Invasive Ductal Carcinoma', 'cellularity': 'High', 'chemotherapy': 0, 'pam50_+_claudin-low_subtype': 'LumB', 'cohort': 4, 'er_status_measured_by_ihc': 'Positve', 'er_status': 'Positive', 'neoplasm_histologic_grade': 3.0, 'her2_status_measured_by_snp6': 'NEUTRAL', 'her2_status': 'Negative', 'tumor_other_histologic_subtype': 'Ductal/NST', 'hormone_therapy': 1, 'inferred_menopausal_state': 'Post', 'integrative_cluster': '10', 'primary_tumor_laterality': nan, 'lymph_nodes_examined_positive': 1, 'mutation_count': 3.0, 'nottingham_prognostic_index': 5.04, 'oncotree_code': 'IDC', 'overall_survival_months': 201.9, 'overall_survival': 0, 'pr_status': 'Negative', 'radio_therapy': 1}
